Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 10-Q


☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31,ended September 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission File Number: 001-36475


AEMETIS, INC.

(Exact name of registrant as specified in its charter)


Delaware

26-1407544

(State or other jurisdiction

(I.R.S. Employer

of incorporation or organization)

Identification No.)

 

20400 Stevens Creek Blvd., Suite 700

Cupertino, CA 95014

(Address of Principal Executive Offices, including zip code)

 

(408) 213-0940

(Registrants telephone number, including area code)


 

Title of each class of registered securities

 

Trading Symbol

 

Name of each exchange on which registered

Common Stock, $0.001 par value

 

AMTX

 

NASDAQ

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes  ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☑ Non-accelerated filer ☐ Smaller reporting company ☑ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The number of shares outstanding of the registrant’s Common Stock on April 30,October 31, 2023 was36,689,72539,451,266 shares.



 

1

 

 

AEMETIS, INC.

 

FORM 10-Q

 

Quarterly Period Ended March 31,September 30, 2023

 

INDEX
   
PART I--FINANCIAL INFORMATION
   
   
Item 1Financial Statements.4
   
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations.33
   
Item 3.Quantitative and Qualitative Disclosures about Market Risk.4143
   
Item 4.Controls and Procedures.4143
   
PART II--OTHER INFORMATION
   
Item 1.Legal Proceedings.4244
   
Item 1A.Risk Factors.4244
   
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.4244
   
Item 3.Defaults Upon Senior Securities.4244
   
Item 4.Mine Safety Disclosures.4244
   
Item 5.Other Information.4244
   
Item 6.Exhibits.4345
   
Signatures4446

 

2

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

On one or more occasions, we may make forward-looking statements in this Quarterly Report on Form 10-Q, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this Quarterly Report on Form 10-Q include, without limitation, statements regarding management’s plans; trends in market conditions with respect to prices for inputs for our products versus prices for our products; our ability to leverage approved feedstock pathways; our ability to leverage our location and infrastructure; our ability to incorporate lower-cost, non-food advanced biofuels feedstock at the Keyes plant; our ability to adopt value-add by-product processing systems; our ability to expand into alternative markets for biodiesel and its by-products, including continuing to expand our sales into international markets; our ability to maintain and expand strategic relationships with suppliers; our ability to continue to develop new and to maintain and protect new and existing intellectual property rights; our ability to adopt, develop and commercialize new technologies; our ability to extend or refinance our senior debt on terms reasonably acceptable to us or at all; our ability to continue to fund operations and our future sources of liquidity and capital resources; our ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for our California Dairy Renewable Natural Gas segment; our ability to fund, develop and operate our carbon capture sequestration projects, including obtaining required permits; our ability to receive awarded grants by meeting all of the required conditions, including meeting the minimum contributions; our ability to sell additional notes under our EB-5 note program and our expectations regarding the release of funds from escrow under our EB-5 note program; our ability to generate and sell or utilize various credits, including LCFS and IRS 45Q tax credits; our ability to improve margins; and our ability to raise additional capital. Words or phrases such as “anticipates,” “may,” “will,” “should,” “could,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous markets and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, the risks set forth under the caption “Risk Factors” below, which are incorporated herein by reference, as well as those business risks and factors described elsewhere in this report and in our other filings with the Securities and Exchange Commission (the “SEC”), including without limitation, our most recent Annual Report on Form 10-K.

 

3

 

 

PART I - FINANCIAL INFORMATION

 

Item 1 - Financial Statements.

AEMETIS, INC.

 

CONSOLIDATED CONDENSED BALANCE SHEETS

(Unaudited, In thousands except for par value)

 

 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Assets

        

Current assets:

  

Cash and cash equivalents ($1,042 and $165 respectively from VIE)

 $4,131  $4,313 

Cash and cash equivalents ($139 and $165 respectively from VIE)

 $3,899  $4,313 

Accounts receivable ($73 and $165 respectively from VIE)

 261  1,264  4,579  1,264 

Inventories, net of allowance for excess and obsolete inventory of $1,040 as of March 31, 2023 and December 31, 2022, respectively

 12,538  4,658 

Prepaid expenses ($470 and $858 respectively from VIE)

 1,502  4,248 

Other current assets ($127 and $725 respectively from VIE)

  2,792   3,653 

Inventories, net of allowance for excess and obsolete inventory of $1,040 as of September 30, 2023, and December 31, 2022, respectively

 8,143  4,658 

Tax Credit Sales receivable ($55,164 and $0 respectively from VIE)

 55,164 - 

Prepaid expenses ($1,937 and $858 respectively from VIE)

 2,895  4,248 

Other current assets ($401 and $725 respectively from VIE)

  3,811   3,653 

Total current assets

  21,224   18,136   78,491   18,136 
  

Property, plant and equipment, net ($70,636 and $71,633 respectively from VIE)

 180,808  180,441 

Operating lease right-of-use assets ($204 and $224 respectively from VIE)

 2,355  2,449 

Other assets ($3,458 and $3,458 respectively from VIE)

  5,994   6,088 

Property, plant and equipment, net ($75,284 and $71,633 respectively from VIE)

 188,076  180,441 

Operating lease right-of-use assets ($165 and $224 respectively from VIE)

 2,159  2,449 

Other assets ($5,267 and $3,458 respectively from VIE)

  8,713   6,088 

Total assets

 $210,381  $207,114  $277,439  $207,114 
  

Liabilities and stockholders' deficit

        

Current liabilities:

  

Accounts payable ($7,660 and $9,192 respectively from VIE)

 $28,508  $26,168 

Accounts payable ($7,103 and $9,192 respectively from VIE)

 $28,800  $26,168 

Current portion of long term debt

 17,419  12,465  24,070  12,465 

Short term borrowings ($21,737 and $19,831 respectively from VIE)

 45,282  36,754 

Short term borrowings ($23,942 and $19,831 respectively from VIE)

 42,415  36,754 

Mandatorily redeemable Series B convertible preferred stock

 4,182  4,082  4,403  4,082 

Accrued property taxes

 1,364  1,206  1,543  1,206 

Current portion of operating lease liability ($43 and $41 respectively from VIE)

 355  338 

Other current liabilities ($200 and $645 respectively from VIE)

  6,518   7,268 

Current portion of operating lease liability ($46 and $41 respectively from VIE)

 390  338 

Other current liabilities ($1,614 and $645 respectively from VIE)

  12,746   7,268 

Total current liabilities

  103,628   88,281   114,367   88,281 

Long term liabilities:

  

Senior secured notes and revolving notes

 158,255  155,843  170,261  155,843 

EB-5 notes

 29,500  29,500  29,500  29,500 

Other long term debt ($29 and $31 respectively from VIE)

 11,479  11,678 

Series A preferred units ($122,546 and $116,000 respectively from VIE)

 122,546  116,000 

Operating lease liability ($104 and $115 respectively from VIE)

 2,095  2,189 

Other long term debt ($9,230 and $31 respectively from VIE)

 20,288  11,678 

Series A preferred units ($137,778 and $116,000 respectively from VIE)

 137,778  116,000 

Operating lease liability ($80 and $115 respectively from VIE)

 1,890  2,189 

Other long term liabilities

  5,298   5,477   3,347   5,477 

Total long term liabilities

  329,173   320,687   363,064   320,687 
  

Stockholders' deficit:

  

Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 1,270 shares issued and outstanding each period, respectively (aggregate liquidation preference of $3,810)

 1  1 

Common stock, $0.001 par value; 80,000 authorized; 36,690 and 35,869 shares issued and outstanding each period, respectively

 37  36 

Series B convertible preferred stock, $0.001 par value; 7,235 authorized; 1,260 and 1,270 shares issued and outstanding each period, respectively (aggregate liquidation preference of $3,780 and $3,810 respectively)

 1  1 

Common stock, $0.001 par value; 80,000 authorized; 39,388 and 35,869 shares issued and outstanding each period, respectively

 39  36 

Additional paid-in capital

 238,272  232,546  255,510  232,546 

Accumulated deficit

 (455,395) (428,985) (449,963) (428,985)

Accumulated other comprehensive loss

  (5,335)  (5,452)  (5,579)  (5,452)

Total stockholders' deficit

  (222,420)  (201,854)  (199,992)  (201,854)

Total liabilities and stockholders' deficit

 $210,381  $207,114  $277,439  $207,114 

 

The accompanying notes are an integral part of the financial statements.

 

4

 

 

AEMETIS, INC.

 

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS)LOSS

(Unaudited, in thousands except for loss per share)

 

 

For the three months ended March 31,

  

For the three months ended September 30,

  

For the nine months ended September 30,

 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Revenues

 $2,151  $52,049  $68,690  $71,831  $115,953  $189,781 

Cost of goods sold

  3,446   55,134   68,198   72,935   114,800   194,184 

Gross loss

 (1,295) (3,085)

Gross profit (loss)

 492  (1,104) 1,153  (4,403)
  

Research and development expenses

 42  36  36  52  115  139 

Selling, general and administrative expenses

  10,786   7,306   8,985   6,439   29,480   21,166 

Operating loss

 (12,123) (10,427) (8,529) (7,595) (28,442) (25,708)
  

Other expense (income):

  

Interest expense

  

Interest rate expense

 7,078  4,435  8,749  5,456  24,126  14,819 

Debt related fees and amortization expense

 1,969  1,826  1,433  1,633  4,732  5,199 

Accretion and other expenses of Series A preferred units

 5,564  1,640  7,739  2,774  20,188  5,920 

Loss on debt extinguishment

 - 49,386 - 49,386 

Gain on litigation

 - - - (1,400)

Other income

  (76)  (41)  (1,853)  (2)  (2,020)  (14,297)

Loss before income taxes

 (26,658) (18,287) (24,597) (66,842) (75,468) (85,335)

Income tax expense (benefit)

  (248)  7   (55,308)  3   (54,490)  13 

Net loss

 $(26,410) $(18,294)

Net income (loss)

 $30,711  $(66,845) $(20,978) $(85,348)
  

Other comprehensive loss

 

Foreign currency translation gain (loss)

  117   (194)

Comprehensive loss

 $(26,293) $(18,488)

Other comprehensive income (loss)

 

Foreign currency translation loss

  (260)  (300)  (127)  (884)

Comprehensive income (loss)

 $30,451  $(67,145) $(21,105) $(86,232)
  

Net loss per common share

 

Net income (loss) per common share

 

Basic

 $(0.73) $(0.54) $0.79  $(1.92) $(0.56) $(2.49)

Diluted

 $(0.73) $(0.54) $0.73  $(1.92) $(0.56) $(2.49)
  

Weighted average shares outstanding

  

Basic

  36,425   33,714  38,881  34,769  37,504  34,344 

Diluted

  36,425   33,714  41,841  34,769  37,504  34,344 

 

The accompanying notes are an integral part of the financial statements.

 

5

 

 

AEMETIS, INC.

 

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 

 

For the three months ended March 31,

  

For the nine months ended September 30,

 
 

2023

  

2022

  

2023

  

2022

 

Operating activities:

        

Net loss

 $(26,410) $(18,294) $(20,978) $(85,348)

Adjustments to reconcile net loss to net cash used in operating activities:

  

Share-based compensation

 2,662  2,040  6,223  4,934 

Depreciation

 1,790  1,336  5,208  4,039 

Debt related fees and amortization expense

 1,969  1,826  4,732  5,199 

Intangibles and other amortization expense

 12  12  35  35 

Accretion and other expenses of Series A preferred units

 5,564  1,640  20,188  5,920 

Deferred tax benefit

 (262) - 

Loss on asset disposals

 - 47 

Loss (gain) on debt extinguishment

 - 49,386 

Warrants issued for working capital agreement

 409 - 

Gain on litigation

 - (1,400)

Loss on lease termination

 - 736 

Deferred tax expense

 (144) - 

Changes in operating assets and liabilities:

  

Accounts receivable

 1,005  911  (3,344) (7,987)

Inventories

 (7,942) 256  (3,616) (5,639)

Prepaid expenses

 2,315  2,457  2,379  2,786 

Other assets

 460  251  (56,797) (505)

Accounts payable

 3,002  833  4,728  12,801 

Accrued interest expense and fees

 5,356  4,691  18,483  8,754 

Other liabilities

  (779)  (6,111)  2,356   (10,065)

Net cash used in operating activities

  (11,258)  (8,152)  (20,138)  (16,307)
  

Investing activities:

        

Capital expenditures

 (7,616) (9,459) (18,595) (28,931)

Grant proceeds and other reimbursements received for capital expenditures

  6,757   1,467   7,682   7,401 

Net cash used in investing activities

  (859)  (7,992)  (10,913)  (21,530)
  

Financing activities:

        

Proceeds from borrowings

 11,583  18,482  41,449  39,860 

Repayments of borrowings

 (2,724) (4,000) (22,586) (16,191)

Lender debt renewal and waiver fee payments

 -  (669) (1,681) (1,169)

Payments on finance leases

 (83) (132) (394) (314)

Proceeds from issuance of common stock in equity offering

 2,617  - 

Proceeds from the exercise of stock options

  -   197 

Proceeds from issuance of common stock

 14,767  7,996 

Proceeds from exercise of stock options

  45   206 

Net cash provided by financing activities

  11,393   13,878   31,600   30,388 
  

Effect of exchange rate changes on cash and cash equivalents

  (56)  (14)  117   (51)

Net change in cash and cash equivalents for period

 (780) (2,280) 666  (7,500)

Cash and cash equivalents at beginning of period

  6,999   7,751   6,999   7,751 

Cash and cash equivalents at end of period

 $6,219  $5,471  $7,665  $251 
  

Supplemental disclosures of cash flow information, cash paid:

  

Cash paid for interest

 $1,515  $4,026  $6,926  $15,476 

Income taxes paid

 14  7  20  10 

Supplemental disclosures of cash flow information, non-cash transactions:

  

Subordinated debt extension fees added to debt

 340  340  680  680 

Debt fees added to revolving lines

 423  500  2,236  800 

Fair value of warrants issued to subordinated debt holders

 448  1,393  1,278  1,939 

Fair value of stock issued to a related party for guarantee fees

 -  2,012  -  2,012 

Fair value of warrants issued to lender for debt issuance costs

 -  3,158  245  3,158 

Fair value of stock issued to lender

 -  1,335  -  1,335 

Lender debt extension, waiver, and other fees added to debt

 384  583  384  583 

Cumulative capital expenditures in accounts payable, including net (decrease) increase of ($511) and $1,535, respectively

 14,900  9,228 

Cumulative capital expenditures in accounts payable, including net increase of $474 and $1,535, respectively

 13,459  15,957 

Payment of debt added to revolving lines

 -  16,266  -  16,266 

Financing lease liabilities arising from obtaining right of use assets

 - 2,932 

Capital expenditures purchased on financing

 - 290 
 

 

The accompanying notes are an integral part of the financial statements.

 

6

 

 

AEMETIS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT

(Unaudited, in thousands)

 

For the three months ended March 31, 2023

 

For the nine months ended September 30, 2023

For the nine months ended September 30, 2023

 
 

Series B Preferred Stock

 

Common Stock

 

Additional

    

Accumulated Other

 

Total

  

Series B Preferred Stock

 

Common Stock

 

Additional

    

Accumulated Other

 

Total

 
             

Paid-in

 

Accumulated

 

Comprehensive

 

Stockholders'

              

Paid-in

 

Accumulated

 

Comprehensive

 

Stockholders'

 

Description

 

Shares

  

Dollars

  

Shares

  

Dollars

  

Capital

  

Deficit

  

Gain (Loss)

  

deficit

  

Shares

  

Dollars

  

Shares

  

Dollars

  

Capital

  

Deficit

  

Gain (Loss)

  

deficit

 
                                  

Balance at December 31, 2022

 1,270  $1  35,869  $36  $232,546  $(428,985) $(5,452) $(201,854) 1,270  $1  35,869  $36  $232,546  $(428,985) $(5,452) $(201,854)
                                  

Issuance of common stock

 -  -  668  1  2,616  -  -  2,617  -  -  668  1  2,616  -  -  2,617 

Stock options exercised

 -  -  40  -  -  -  -  -  -  -  40  -  -  -  -  - 

Stock-based compensation

 -  -  -  -  2,662  -  -  2,662  -  -  -  -  2,662  -  -  2,662 

Issuance and exercise of warrants

 -  -  113  -  448  -  -  448  -  -  113  -  448  -  -  448 

Foreign currency translation gain

 -  -  -  -  -  -  117  117  -  -  -  -  -  -  117  117 

Net loss

  -   -   -   -   -   (26,410)  -   (26,410)  -   -   -   -   -   (26,410)  -   (26,410)

Balance at March 31, 2023

  1,270  $1   36,690  $37  $238,272  $(455,395) $(5,335) $(222,420)  1,270  $1   36,690  $37  $238,272  $(455,395) $(5,335) $(222,420)
                 

Issuance of common stock

 - - 1,353 1 6,298 - - 6,299 

Series B conversion to common stock

 (10) - 1 - - - - - 

Stock options exercised

 - - 72 - 38 - - 38 

Stock-based compensation

 - - - - 1,755 - - 1,755 

Issuance and exercise of warrants

 - - 62  654   654 

Foreign currency translation gain

 - - - - - - 16 16 

Net loss

  -  -  -  -  -  (25,279)  -  (25,279)

Balance at June 30, 2023

  1,260 $1  38,178 $38 $247,017 $(480,674) $(5,319) $(238,937)
                 

Issuance of common stock

 - - 1,062 1 5,850 - - 5,851 

Stock options exercised

 - - 35 - 7 - - 7 

Stock-based compensation

 - - - - 1,806 - - 1,806 

Issuance and exercise of warrants

 - - 113 - 830 - - 830 

Foreign currency translation loss

 - - - - - - (260) (260)

Net income

  -  -  -  -  -  30,711  -  30,711 

Balance at September 30, 2023

  1,260 $1  39,388 $39 $255,510 $(449,963) $(5,579) $(199,992)

 

For the three months ended March 31, 2022

 

For the nine months ended September 30, 2022

For the nine months ended September 30, 2022

 
 

Series B Preferred Stock

 

Common Stock

 

Additional

    

Accumulated Other

 

Total

  

Series B Preferred Stock

 

Common Stock

 

Additional

    

Accumulated Other

 

Total

 
             

Paid-in

 

Accumulated

 

Comprehensive

 

Stockholders'

              

Paid-in

 

Accumulated

 

Comprehensive

 

Stockholders'

 

Description

 

Shares

  

Dollars

  

Shares

  

Dollars

  

Capital

  

Deficit

  

Loss

  

deficit

  

Shares

  

Dollars

  

Shares

  

Dollars

  

Capital

  

Deficit

  

Loss

  

deficit

 
                                  

Balance at December 31, 2021

 1,275  $1  33,461  $33  $205,305  $(321,227) $(4,350) $(120,238) 1,275  $1  33,461  $33  $205,305  $(321,227) $(4,350) $(120,238)
                                  

Issuance of common stock

 -  -  341  1  3,348  -  -  3,349  -  -  341  1  3,348  -  -  3,349 

Series B conversion to common stock

 (5) - 1 - - - - -  (5) - 1 - - - - - 

Stock options exercised

 -  -  263  -  196  -  -  196  -  -  263  -  196  -  -  196 

Stock-based compensation

 -  -  -  -  2,040  -  -  2,040  -  -  -  -  2,040  -  -  2,040 

Issuance and exercise of warrants

 -  -  113  -  4,550  -  -  4,550  -  -  113  -  4,550  -  -  4,550 

Foreign currency translation loss

 -  -  -  -  -  -  (194) (194) -  -  -  -  -  -  (194) (194)

Net loss

  -   -   -   -   -   (18,294)  -   (18,294)  -   -   -   -   -   (18,294)  -   (18,294)

Balance at March 31, 2022

  1,270  $1   34,179  $34  $215,439  $(339,521) $(4,544) $(128,591)  1,270  $1   34,179  $34  $215,439  $(339,521) $(4,544) $(128,591)
                 

Issuance of common stock

 - - 400 1 5,123 - - 5,124 

Stock options exercised

 - - 3 - 4 - - 4 

Stock-based compensation

 - - - - 1,349 - - 1,349 

Foreign currency translation loss

 - - - - - - (390) (390)

Net loss

  -  -  -  -  -  (209)  -  (209)

Balance at June 30, 2022

  1,270 $1  34,582 $35 $221,915 $(339,730) $(4,934) $(122,713)
                 

Issuance of common stock

 - - 319 - 2,872 - - 2,872 

Stock options exercised

 - - 29 - 5 - - 5 

Stock-based compensation

 - - - - 1,545 - - 1,545 

Issuance and exercise of warrants

 - - 113 - 546 - - 546 

Foreign currency translation loss

 - - - - - - (300) (300)

Net loss

  -  -  -  -  -  (66,845)  -  (66,845)

Balance at September 30, 2022

  1,270 $1  35,043 $35 $226,883 $(406,575) $(5,234) $(184,890)

 

The accompanying notes are an integral part of the financial statements.

 

7

(Tabular data in thousands, except par value and per share data) 
 

1. Nature of Activities and Summary of Significant Accounting Policies

 

Nature of Activities. Founded in 2006 and headquartered in Cupertino, California, Aemetis, Inc. (collectively with its subsidiaries on a consolidated basis referred to herein as “Aemetis,” the “Company,” “we,” “our” or “us”) is an international renewable natural gas and renewable fuels company focused on the acquisition, development and commercialization of innovative low and negative carbon intensity products and technologies that replace traditional petroleum-based products. We operate in three reportable segments consisting of “California Ethanol,” “California Dairy Renewable Natural Gas,” and “India Biodiesel.” We have other operating segments determined not to be reportable segments and are collectively represented by the “All Other” category. At Aemetis, our mission is to generate sustainable and innovative renewable fuel solutions that benefit communities and restore our environment. We do this by building a local circular bioeconomy utilizingusing agricultural waste to produce low carbon, advanced renewable fuels that reduce greenhouse gas ("GHG") emissions and improve air quality by replacing traditional petroleum-based products.

 

Our California Ethanol segment consists of a 65 million gallon per year capacity ethanol production facility located in Keyes, California (the “Keyes Plant”) that we own and operate. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains (“WDG”), Distillers Corn Oil (“DCO”), Carbon Dioxide (“CO₂”) and Condensed Distillers Solubles (“CDS”), all of which are sold as animal feed to local dairies and feedlots, with CO₂ sold to food, beverage, and industrial customers. We have several energy efficiency initiatives at the Keyes Plant focused on significantly lowering the carbon intensity of our fuels. In the third quarter of 2022,ZEBREXTM ethanol dehydration system completed installation and began commissioning, a key first step in the electrification of the Keyes Plant, which will significantly reduce the use of petroleum-based natural gas as process energy.fuels. During the last two weeks of December 2022, we undertook an extended maintenance cycle and accelerated the implementation of several important ethanol plant energy efficiency plant upgrades noted above.upgrades. Our decision was partly driven by the high natural gas prices in Northern California during the period. Furthermore, after monitoring natural gas pricing and margin profitability, we decided to extendextended the maintenance cycle throughinto the first and second quarters of 2023 and restarted the plant near the end of the first quarter of 2023. As such, revenues from the Keyes Plant during the first quarter of 2023 were limited to sales of stored inventory at the plant. With natural gas pricing in a reasonable range and the maintenance turn-around complete, we expect to restart the plant during the second quarter of 2023.quarter.

 

Our California Dairy Renewable Natural Gas segment, which consists of our subsidiary Aemetis Biogas LLC “Aemetis Biogas”and its subsidiaries, ("Aemetis Biogas" or “ABGL,”"ABGL"), constructs and operates bio-methane anaerobic digesters at local dairies near the Keyes Plant (many of whom also purchase WDG produced by the Keyes Plant as animal feed); transports the biogas via pipeline to the Keyes Plant site; and converts the biogas to Renewable Natural Gas (“RNG”) which is then delivered to customers through the PG&E natural gas pipeline.

The Aemetis Biogas network includes the Aemetis Biogas Central Dairy Project which operates 40 miles of completed biogas pipeline; six operating dairy digesters; five dairy digesters that are under construction; a centralized biogas-to-RNG conversion facility located at the Keyes Plant site; and a renewable natural gas interconnection with the PG&E utility gas pipeline.

 

The dairy digesters are connected via an underground private pipeline owned by ABGL to a gas cleanup and compression unit at the Keyes Plant to produce dairy RNG. Upon receiving the bio-methane from the dairies, impurities are removed, and the bio-methane is converted to negative carbon intensity RNG that is injected into the statewide PG&E gas utility pipeline for use as transportation fuel or used as renewable process energy at the Keyes Plant.

Our India Biodiesel segment owns and operates a plant in Kakinada, India (“Kakinada Plant”) with a nameplate capacity of 150 thousand metric tons per year, or about 50 million gallons per year, producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. We believe the Kakinada Plant is one of the largest biodiesel production facilities in India on a nameplate capacity basis. The Kakinada Plant is capable of processing a variety of vegetable oils and animal fat waste feedstocks into biodiesel that meets international product standards. Our Kakinada Plant can also distill the crude glycerin byproduct from the biodiesel refining process into refined glycerin, which is sold to the pharmaceutical, personal care, paint, adhesive, and other industries. The Kakinada Plant shipped the tender offer orders placed during the third quarter of 2022 in the fourth quarter of 2022.As such, revenues from the Kakinada Plant during the first quarter of 2023 were limited to sales of stored inventory at the plant to private customers. In April 2023, Kakinada Plant was awarded a new tender offer to ship $34.0 million worth of biodiesel. 

 

Our All Other segment consists of: the development of our Carbon Zero biofuels production plantsplant to produce renewable diesel and sustainable aviation fuel; the development of Carbon Capture and Sequestration compression system and injection wells; operation of the Riverbank Industrial Complex; a research and development facility in Minneapolis Minnesota; and our corporate offices in Cupertino, California.

 

8

(Tabular data in thousands, except par value and per share data) 
 

Our Carbon Zero biofuels production plants are designed to produce low or negative carbon intensity sustainable aviation fuel (“SAF”) and renewable diesel fuel (“RD”) utilizingusing low carbon hydroelectric electricity, renewable hydrogen and non-edible renewable oils sourced from existing Aemetis biofuels plants and other sources. The first Carbon Zero plant is scheduled to be built in Riverbank, California at the 125-acre former Riverbank Army ammunition plant.  The Riverbank plant is expected to utilize zero carbon hydroelectric and other renewable power available onsite to produce SAF, RD, and other byproducts.  

 

Our Carbon Capture subsidiary was established to build Carbon Capture and Sequestration (“CCS”) projects that generate LCFS and IRS 45Q tax credits by compressing and injecting CO₂ into deep wells whichthat are monitored for emissions to ensure the long-term sequestration of carbon underground. In July 2022, Aemetis purchased 24 acres located on the Riverbank Industrial Complex site in Riverbank, California to develop a CCS injection well.

 

Basis of Presentation and Consolidation. These consolidated financial statements include the accounts of Aemetis. Additionally, weAemetis, Inc. and its subsidiaries. We consolidate all entities in which we have a controlling financial interest. A controlling financial interest is usually obtained through ownership of a majority of the voting interests. However, an enterprise must consolidate a variable interest entity (“VIE”) if the enterprise is the primary beneficiary of the VIE, even if the enterprise does not own a majority of the voting interests. The primary beneficiary is the party that has both the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. ABGL was assessed to be a VIE and through the Company’s ownership interest in all of the outstanding common stock, the Company has been determined to be the primary beneficiary and accordingly, the assets, liabilities, and operations of ABGL are consolidated into those of the Company.in these financial statements.

 

All intercompany balances and transactions have been eliminated in consolidation.

 

The accompanying consolidated condensed balance sheet as of March 31,September 30, 2023, the consolidated condensed statements of operations and comprehensive loss for the three and ninemonths ended March 31,September 30, 2023 and 2022, the consolidated condensed statements of cash flows for the threenine months ended March 31,September 30, 2023 and 2022, and the consolidated condensed statements of stockholders’ deficit for the three and ninemonths ended March 31,September 30, 2023 and 2022 are unaudited. The consolidated condensed balance sheet as of December 31, 2022, was derived from the 2022 audited consolidated financial statements and notes thereto. The consolidated condensed financial statements in this report should be read in conjunction with the 2022 audited consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2022. The accompanying consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations.

 

In the opinion of Company’s management, the unaudited interim consolidated condensed financial statements as of and for the three and ninemonths ended March 31,September 30, 2023 and 2022 have been prepared on the same basis as the audited consolidated statements as of and for the year ended December 31, 2022 and reflect all adjustments, consisting primarily of normal recurring adjustments, necessary for the fair presentation of its statement of financial position, results of operations and cash flows. The results of operations for the three and ninemonths ended March 31,September 30, 2023 are not necessarily indicative of the operating results for any subsequent quarter, for the full fiscal year or any future periods.

 

Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, revenues, and expenses during the reporting period. To the extent there are material differences between these estimates and actual results, the Company’s consolidated financial statements will be affected.

Revenue Recognition. We derive revenue primarily from sales of ethanol and related co-products in North America,California, renewable natural gas and related environmental attributes in California, and biodiesel and refined glycerin in India pursuant to supply agreements and purchase order contracts. We assessed the following criteria under the Accounting Standards Codification (“ASC”) 606 guidance: (i) identify the contracts with customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when the entity satisfies the performance obligations.

 

9

(Tabular data in thousands, except par value and per share data) 
 

California Ethanol: Ethanol Revenues: On May 13, 2020, we entered into an amendment to thethe Corn Procurement and Working Capital Agreement with J.D. Heiskell (the “Corn Procurement and Working Capital”), pursuant to which we buy all corn from J.D. Heiskell and sell all WDG and corn oil we produce to J.D. Heiskell. Effective October 1, 2021, we entered into Fuel Ethanol Purchase and Sale Agreement with Murex LLC (“Murex”), inpursuant to which we sellsold all our ethanol to Murex through individual sales transactions. On May 25, 2023, we entered into the second amendment to the Aemetis Keyes Grain Procurement and Working Capital Agreement with J.D. Heiskell, the second amendment to the Corn Procurement and Working Capital Agreement with J.D. Heiskell, and the second amendment to the Keyes Ethanol and Corn Tank Lease with J.D. Heiskell. The amendments provide that (i) the Keyes Plant will receive a temporary increase to its working capital credit limit by an amount equal to four days of grain payables repayable in equal daily installments over 120 days, (ii) that J.D. Heiskell will buy all Ethanol, WDG, CDS, and Corn Oil produced by the Keyes Plant, sell all ethanol to certain designated purchasers and pay us the same price as it received from such sales, and (iii) J.D. Heiskell will lease certain ethanol product storage tanks from the Keyes Plant. Given the similarity of the individual sales transactions with Murex,J.D. Heiskell, we have assessed them as a portfolio of similar contracts. ThePrior to May 25, 2023, the performance obligation was satisfied by delivery of the physical product from our finished goods tank to our customer’s contracted trucks. Effective on May 25, 2023, the performance obligation is satisfied by delivery of the physical product to one of our customer’s contracted trucking companies.the finished goods tank leased by J.D. Heiskell. Upon delivery, the customer has the ability to direct the use of the product and receive substantially all of its benefits. The transaction price is determined based on daily market prices negotiated by Murex for ethanol and by our marketing partner A.L. Gilbert Company (“A.L. Gilbert”) for WDG. The transaction price is allocated to one performance obligation.

 

The belowfollowing table shows our sales in our California Ethanol segment by product category:

 

 

For the three months ended March 31,

  

For the three months ended September 30,

  

For the nine months ended September 30,

 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Ethanol sales

 $368  $37,896  $36,375  $44,673  $45,388  $130,224 

Wet distiller's grains sales

 -  11,517 

Wet distillers grains sales

 9,427  13,003  11,980  39,669 

Other sales

  107   2,628   1,637   3,232   1,878   8,947 
 $475  $52,041 

Total

 $47,439 $60,908 $59,246 $178,840 

 

We have elected to adopt the practical expedient that allows for ignoring the significant financing component of a contract when estimating the transaction price when the transfer of promised goods to the customer and customer payment for such goods are expected to be within one year of contract inception. Further, we have elected to adopt the practical expedient in which incremental costs of obtaining a contract are expensed when the amortization period would otherwise be less than one year.

 

For ethanol, we only have customer relationships with Murex, hence the principal and agent criteria are not applied. However, we are still buying corn and selling WDG and corn oil to J.D.Heiskell. We analyzed thealso assessed principal versus agent relationship criteria below.

as we buy our feedstock from our customer and process and sell finished goods to that same customer. Specifically, we buy corn as feedstock in producing ethanol from our working capital partner J.D. Heiskell and we sell all ethanol, WDG, CDO, and CDS produced to J.D. Heiskell. Our ethanol finished goods tank is leased to J.D. Heiskell and legal title to the product is transferred upon transfer of our finished ethanol to this location. We consider the purchase of corn as a cost of goods sold and consider the sale of ethanol as revenue upon transfer to the finished goods tank and consider the sale of WDG, CDO, and corn oil,CDS as revenue, upon trucks leaving the Keyes Plant as revenuewith the product, on the basis that (i) we control and bear the risk of gain or loss on the processing of corn which is purchased at market prices into ethanol and (ii) we have legal title to the goods during the processing time. The pricing for bothethanol, WDG, CDO, and corn oilCDS is set independently. Revenues from WDGethanol and corn oilWDG are billed net of the related transportation and marketing charges. The transportation component is accounted for in cost of goods sold and the marketing component is accounted for in sales, general and administrative expense. Transportation and marketing charges are known within days of the transaction and are recorded at the actual amounts. We have elected an accounting policy under which these charges have been treated as fulfillment activities provided after control has transferred. As a result, these charges are recognized in cost of goods sold and selling, general and administrative expenses, respectively, when revenue is recognized. Revenues are recorded at the gross invoiced amount. Hence, we are the principal in California Ethanol segment where our customer and vendor may be the same.

 

California Dairy Renewable Natural Gas:Gas Revenues: InSince December 2018,we utilizedhave used our relationships with California’s Central Valley dairy farmers by signingto sign leases and raisingraise funds to construct dairy digesters, a 40 mile-mile RNG collection pipeline, a centralized biogas cleanupupgrading hub, and a renewable natural gas interconnection with PG&E&E’s natural gas pipeline. We are currently producingAs of September 30, 2023, we have seven operating dairy digesters that produce biomethane, five additional digesters under construction, and contracts with additional dairies planned for future construction of digesters. Our RNG from sixupgrading hub converts the biomethane produced by the digesters connected to 40 miles of pipeline, then flowing this gas to our RNG cleanup hub and delivering the gas through an interconnect to the PG&E pipeline at the Keyes Plant. The RNG upgrade unit at the Keyes Plant is designed deliverinto utility-grade RNG for sale as transportation fuelthat is transported by PG&E’s pipeline to California customers via pipeline delivery.

We have 30 signed agreements with dairies to construct dairy digesters.for use as transportation fuel.  Our revenue development strategy for the Dairy Renewable Natural Gas segment relies upon continuing to collect bio-methane gas from the existingbuild new dairy digesters continuing to build out the network of dairy digesters,and extending the pipeline in Northern California to growcollection pipeline. We have been storing some of our RNG production and postponing the supplydispensing of RNG available for saletransportation use in order to increase the quantity and utilizing the biogas-to-RNG upgrade unit to distribute utility-grade RNG to customers statewide. We plan to store the RNG until thevalue of LCFS credit pathway for each dairy has been established, after which we will sell the stored gas by delivering it into the utility gas pipeline .credits.  As of March 31,September 30, 2023, we have 31.064.69 thousand MMBtu of RNG that has been produced by not yet dispensed for use in storage. Thetransportation. This RNG in storage is recorded as inventory valued at the lower of cost and net realizable value.  The value perWhen dispensed, it will generate LCFS as of March 31, 2023 was $70 per metric toncredits and the value per D3 Cellulosic RIN was $1.96; for an estimated market value $53.37 per MMBtu, assuming a CI score of -RINs that are 427.not currently reflected in our assets.

 

10

(Tabular data in thousands, except par value and per share data)
 
 

India Biodiesel:Biodiesel Revenues: We sell products pursuant to purchase orders (written or verbal) or by contract with governmental or international parties, in which performance is satisfied by delivery and acceptance of the physical product. Given that the contracts are sufficiently similar in nature, we have assessed these contracts as a portfolio of similar contracts as allowed under the practical expedient. Doing so does not result in a materially different outcome compared to individually accounting for each contract. All domestic and international deliveries are subject to certain specifications as identified in contracts. The transaction price is determined daily based on reference market prices for biodiesel, refined glycerin, and PFAD, net of taxes. Transaction price is allocated to one performance obligation.

 

The belowfollowing table shows our sales in our India Biodiesel segment by product category:

 

 

For the three months ended March 31,

  

For the three months ended September 30,

  

For the nine months ended September 30,

 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Biodiesel sales

 $1,190  $-  $19,291  $10,828  $53,292  $10,828 

Other sales

  280   8   853   95   1,892   113 
 $1,470  $8 

Total

 $20,144 $10,923 $55,184 $10,941 

 

In India, we also assessed principal versus agent criteria as in some cases we buy our feedstock from our customers and process and sell finished goods to those same customers in certain contractual agreements.customers. In those cases, we receive the legal title to feedstock from our customers once it is on our premises. We control the processing and production of biodiesel based on contract terms and specifications. The pricing for both feedstock and biodiesel is set independently. We hold the title and risk to biodiesel according to agreements when we enter into in these situations. Hence, we are the principal in India sales scenarios where our customer and vendor may be the same.

Cost of Goods Sold. Cost of goods sold includes those costs directly associated with the production of revenues, such as raw material consumed, factory overhead and other direct production costs. During periods of idle plant capacity, costs otherwise charged to cost of goods sold are reclassified to selling, general and administrative expense.

Shipping and Handling Costs. Shipping and handling costs are classified as a component of cost of goods sold in the accompanying consolidated statements of operations.

 

Research and Development. Research and development costs are expensed as incurred, unless they have alternative future uses to the Company.

 

Cash, Cash Equivalents, and Restricted Cash. The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company maintains cash balances at various financial institutions domestically and abroad. The Federal Deposit Insurance Corporation insures domestic cash accounts. The Company’s accounts at these institutions may at times exceed federally insured limits. The Company has not experienced any losses in such accounts. Amounts included in restricted cash represent those required to be set aside by the Construction Loan Agreement with Greater Nevada Credit Union ("GNCU") for financing reserves and construction contingencies and will be released upon approval by GNCU. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheet to the total of the same such amounts shown in the statement of cash flows.

 

 

As of

 

As of

 
 

March 31, 2023

 

December 31, 2022

 

September 30, 2023

  

December 31, 2022

 

Cash and cash equivalents

 

$ 4,131

 

$ 4,313

 $3,899  $4,313 

Restricted cash included in other current assets

 

127

 

725

 401  725 

Restricted cash included in other assets

 

1,961

 

1,961

  3,365   1,961 

Total cash, cash equivalents, and restricted cash shown in the statement of cash flows

 

$ 6,219

 

$ 6,999

 $7,665  $6,999 

 

Accounts Receivable. The Company sells ethanol and WDG through third-party marketing arrangements generally without requiring collateral directly to customers on a variety of terms including advanced payment terms, based on the size and creditworthiness of the customer. DCO is marketed and sold to A.L. Gilbert and other customers under the J.D. Heiskell Purchasing Agreement. The Company sells CDS directly to customers on standard 30 day-day payment terms. The Company sells biodiesel, glycerin, and processed natural oils to a variety of customers and may require advanced payment based on the size and creditworthiness of the customer. Usually, invoices are due within 30-days days on net terms. Accounts receivables consist of product sales made to large creditworthy customers. Trade accounts receivable areis presented at original invoice amount, net of any allowance for doubtful accounts.credit losses. We did not reserve any balance for allowances for doubtful accountscredit losses as of March 31,September 30, 2023and December 31, 2022.

 

11

(Tabular data in thousands, except par value and per share data)
 
 

The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivables are charged against the allowance for doubtful accounts once un-collectability has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, additional allowances may be required. 

Inventories. Finished goods, raw materials, and work-in-process inventories are valued using methods which approximate the lower of cost (first-in, first-out) or net realizable value (“NRV”). Distillers’ grains and related products are stated at NRV. In the valuation of inventories, NRV is determined as estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

Variable Interest Entities. We determine at the inception of each arrangement whether an entity in which we have made an investment or in which we have other variable interests in is considered a variable interest entity (“VIE”). We consolidate VIEs when we are the primary beneficiary. The primary beneficiary of a VIE is the party that meets both of the following criteria: (1) has the power to make decisions that most significantly affect the economic performance of the VIE; and (2) has the obligation to absorb losses or the right to receive benefits that in either case could potentially be significant to the VIE. Periodically, we assess whether any changes in our interest or relationship with the entity affects our determination of whether the entity is still a VIE and, if so, whether we are the primary beneficiary. If we are not the primary beneficiary in a VIE, we account for the investment or other variable interests in a VIE in accordance with applicable U.S. GAAP.

Property, Plant and Equipment. Property, plant, and equipment are carried at cost less accumulated depreciation after assets are placed in service and are comprised primarily of plant and buildings, furniture, machinery, equipment, land, and biogas dairy digesters. Capital expenses for in-process projectprojects are accumulated incapitalized as construction in progress and will be capitalized and depreciated once the capital projects are finished and are in service. The Company’s plant in Goodland, Kansas (the ”Goodland Plant”"Goodland Plant") is partially completed and is not ready for operation. It is the Company’s policy to depreciate capital assets over their estimated useful lives using the straight-line method.

 

The Company evaluates the recoverability of long-lived assets with finite lives in accordance with ASC Subtopic 360-10-35 Property Plant and EquipmentSubsequent Measurements, which requires recognition of impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. When events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, based on estimated undiscounted cash flows, the impairment loss would be measured as the difference between the carrying amount of the assets and its estimated fair value. The Company has not recorded any impairment during the three and ninemonths ended March 31,September 30, 2023 and 2022.

California Energy Commission Low-Carbon Fuel Production Program. The Company has beenwas awarded $4.2 million in matching grants from the California Energy Commission Low-Carbon Fuel Production Program (“LCFPP”). The LCFPP grant reimburses the Company for costs to design, procure, and install a processing facility to clean-up, measure and verify negative-carbon intensity dairy renewable natural gas fuel at the production facility in Keyes, California. The Company has received $3.8 million from the LCFPP as of March 31,September 30, 2023, as reimbursement for actual costs incurred. Due to the uncertainty associated with the approval process under the grant program, the Company recognized the grant as a reduction of costs in the period when the grant payment iswas received.

 

CDFA Dairy Digester Research and Development programIn October 2020, the Company was awarded $7.8 million in matching grants from the CDFA Dairy Digester Research and Development program. The CDFA grant reimburses the Company for costs required to permit and construct six of the Company’s biogas capture systems under contract with central California dairies. The Company has received $3.9$4.8 million from the CDFA 2020 grant program as of March 31,September 30, 2023, as reimbursement for actual costs incurred. Due to the uncertainty associated with the approval process under the grant program, the Company recognized the grant as a reduction of costs in the period when the grant payment iswas received.

12

(Tabular data in thousands, except par value and per share data)
 
 

California Energy Commission Low Carbon Advanced Ethanol Grant Program. In May 2019, the Company was awarded the right to receive reimbursements from the California Energy Commission Community-Scale and Commercial-Scale Advanced Biofuels Production Facilities grant under the Alternative and Renewable Fuel and Vehicle Technology Program in an amount up to $5.0 million (the “CEC Reimbursement Program”) in connection with the Company’s expenditures toward the development of the Riverbank Carbon Zero Facility. To comply with the guidelines of the CEC Reimbursement Program, the Company must make a minimum of $7.9 million in matching contributions to the Riverbank project. The Company receives fundshas received $1.7 million under the CEC Reimbursement Program for actual expenses incurred up to $5.0 million as long as the Company makes the minimum matching contribution. Given that the Company has not made the minimum matching contribution, the grant, for reimbursement of capital expenditures of $1.7 millionwhich is presented with long-termcurrent-term liabilities as of March 31,September 30, 2023,, and December 31, 2021.2022.  DueOn September 30, 2023, the CEC program decided not to extend the time for the Company to receive additional grant funds due to the uncertainty associated with meetingrequirement to achieve the minimum matching contribution, the reimbursement will be recognized grant program objectives by June 30, 2024, when the Company makes the minimum matching contribution.CEC program ends.

 

U.S. Department of Food and Agriculture Forest Service Grant. Aemetis Advanced Products Keyes (“AAPK”) has been awarded $245 thousand in matching grants from the U.S. Department of Food and Agriculture Forest Service (“US Forest Service”) under the Wood Innovation and Community Wood program. The grant reimburseshas reimbursed the Company for continued development of technologies and processes to valorize forest waste for the production of cellulosic ethanol.  AAPK has received $216all $245 thousand awarded from the US Forest Service asfor reimbursement forof actual allowable program costs incurred through March 31,September 30, 2023.

California Energy Commission Grant for Solar Microgrid, DSC and Battery Backup System. Aemetis Advanced Fuels Keyes (“AAFK”) has been awarded an $8.0 million grant to design, construct and commission a grid-connected 1.56 MW photovoltaic microgrid and 1.25MW/2.5MWh Battery Energy Storage System integrated with an artificial intelligence-driven distributed control system (DCS). The Company has made the required $1.6 million in matching contributions to qualify to receive grant reimbursements. AAFK received $4.2 million in grant funds from this program as reimbursement for actual expenditures incurred through March 31,September 30, 2023. Due to the uncertainty associated with the approval process under the grant program, the Company recognized the grant as a reduction of costs in the period when grant payment iswas received.

 

California Department of Forestry and Fire Protection Grant. AAPK has been awarded $2 million in matching grants from the CAL FIRE Business and Workforce Development Grant Program (“CAL Fire”) in May 2022. This CAL Fire grant program reimburses AAPK for costs to design, construct, and commission a 2 million gallon per year cellulosic ethanol facility able to convert conifer biomass from forested regions of the Sierra Nevada into an ultra‐low carbon biofuel derived from 100% forest biomass (“CAL Fire Conversion Program”). AAPK must contribute $5.8 million in cost share contributions to the project to receive grant proceeds. AAPK has received no grant funds from the CAL Fire Conversion Program as reimbursement for actual costs through March 31,September 30, 2023.

California Department of Forestry and Fire Protection Grant. AAPK was awarded $500 thousand in grants from CAL Fire in May 2022. This CAL Fire grant program reimburses AAPK for costs to advance a new‐to‐the world technology that circumvents current limitations surrounding the extraction of cellulosic sugars by pioneering a novel route for deconstructing woody biomass using ionic liquids (“CAL Fire Extraction Program”). AAPK has received no grant funds from the CAL Fire Extraction Program as reimbursement for actual costs through March 31,September 30, 2023.

U.S Forest Service Community Wood Grant. Aemetis Advanced Products Riverbank (“AAPR”) was awarded $642 thousand in matching grants from the U.S Forest Service Wood Innovations Program (“USFS”) in May 2022. The USFS grant program reimburses AAPR for costs to design, construct, and commission a plant to produce cellulosic ethanol using preliminary research and development in partnership with the Joint Bioenergy Institute (JBEI). USFS grant funds will be used to complete the FEL-3 design phase of the entire process, construct a biomass pretreatment unit to extract sugars at the Aemetis Riverbank site and ferment sugars into ethanol at the Keyes Plant. AAPR must contribute $2.4 million in cost share contributions to the project to receive grant proceeds. AAPK has received no grant funds from the USFS grant program as reimbursement for actual costs through March 31,September 30, 2023.

California Energy Commission Grant for Mechanical Vapor Recompression System. Aemetis Advanced Fuels Keyes (“AAFK”) has been awarded a $6.0 million grant to design, construct and commission a mechanical vapor recompression (MVR) system. The additional evaporation stages will eliminate natural gas consumption and related greenhouse gas emissions in the evaporation portion of the process by installing metering equipment and software to monitor and optimize the plant’s energy consumption. The MVR system will compress vapor to a higher pressure and temperature so that it can be recycled multiple times as steam heat in the evaporation process, which will dramatically reduce natural gas use. The grant requires $5.3 million in matching contributions. AAFK has received no grant funds from this program as reimbursement for actual expenditures incurred through March 31,September 30, 2023. Due to the uncertainty associated with the approval process under the grant program, the Company will recognize future grant proceeds received as a reduction of costs in the period when payment isgrant payments will be received.

13

(Tabular data in thousands, except par value and per share data)
 
 

Pacific Gas and Electric SEM Manufacturers Incentive Program. During the fourth quarter of 2022, AAFK received $374 thousand in PG&E SEM Incentive Program reimbursements for installing more efficient beer feed heat exchangers. The Company has received $27 thousand in PG&E SEM Incentive Program reimbursements in 2023.Third party consultants verified the reduction in natural gas usages from the new heat exchangers to obtain the incentive program funds.

 

California Energy Commission PG&E A2313 Pipeline Interconnection Grant. The Company has received $5 million in matching grants from the California Energy Commission PG&E A2313 Pipeline Interconnection program (“CEC PG&E Pipeline Interconnect”) during the quarter ended March 31, 2023. The CEC PG&E Pipeline Interconnect grant reimburses the Company for actual costs to design, procure, and install facility and pipeline to interconnect renewable natural gas pipeline with the PG&E utility pipeline. In October 2022 the Company successfully connected and commissioned pipeline interconnection with the PG&E utility pipeline. After three months of renewable natural gas delivery, verified the interconnection verification process was completed, and the CEC PG&E program funds were released. The Company has received all $5 million available from the PG&E program as reimbursement for actual costs incurred as ofthrough March 31,2023.Given the nature of funds received as reimbursement for actual costs incurred, the funds were applied against the actual costs.

Investment Tax Credit. In the third quarter of 2023, the Company sold to a third-party purchaser certain transferrable Investment Tax Credits (ITCs) that had been generated by the Company from its investments in the California Dairy Renewable Natural Gas segment.  The Company accounted for the ITC sale in accordance with ASC 740 by electing the flow-through method. The net value of tax credits sale of $55.2 million is recorded as other receivable on the balance sheet and as an income tax benefit in the income statement as of September 30, 2023.

 

Basic and Diluted Net Loss(Loss) per Share.Basic net lossincome (loss) per share is computed by dividing netincome or loss attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted net lossincome/(loss) per share reflects the dilution of common stock equivalents such as options, convertible preferred stock, debt and warrants to the extent the impact is dilutive. As the Company incurred net income for the three months ended September 30, 2023, potentially dilutive securities have been included in the diluted net income per share computations and any potentially anti-dilutive shares have been excluded and are shown in the second table below. As the Company incurred net losses for the three months ended March 31,September 30, 2022 and nine months ended September 30, 2023 and 2022,, potentially dilutive securities have been excluded from the diluted net loss per share computations as their effect would be anti-dilutive.

  

For the three months ended September 30,

 

For the nine months ended September 30,

  

2023

 

2022

 

2023

 

2022

Net income (loss)

 

$ 30,711

 

$ (66,845)

 

$ (20,978)

 

$ (85,348)

Shares:

        

Weighted average shares outstanding—basic

 

38,881

 

34,769

 

37,504

 

34,344

         

Weighted average dilutive share equivalents from preferred shares

 

126

 

-

 

-

 

-

Weighted average dilutive share equivalents from stock options

 

2,808

 

-

 

-

 

-

Weighted average dilutive share equivalents from common warrants

 

26

 

-

 

-

 

-

         

Weighted average shares outstanding—diluted

 

41,841

 

34,769

 

37,504

 

34,344

         

Income (loss) per share—basic

 

$ 0.79

 

$ (1.92)

 

$ (0.56)

 

$ (2.49)

         

Income (loss) per share—diluted

 

$ 0.73

 

$ (1.92)

 

$ (0.56)

 

$ (2.49)

 

The following table shows the number of potentially dilutive shares excluded from the diluted net loss per share calculation as of March 31,September 30, 2023 and 2022:

 

  

As of

 
  

March 31, 2023

  

March 31, 2022

 

Series B preferred (post split basis)

  127   127 

Common stock options and warrants

  6,125   4,774 

Debt with conversion feature at $30 per share of common stock

  1,246   1,223 

Total number of potentially dilutive shares excluded from the diluted net (loss) per share calculation

  7,498   6,124 

 

  

As of

 
  

September 30, 2023

  

September 30, 2022

 

Series B preferred (post split basis)

  -   127 

Common stock options and warrants

  3,281   5,064 

Debt with conversion feature at $30 per share of common stock

  1,259   1,256 

Total number of potentially dilutive shares

  4,540   6,447 

Comprehensive Income (Loss). ASC 220 Comprehensive Income (Loss) requires that an enterprise report, by major components and as a single total, the change in its net assets from non-owner sources. The Company’s other comprehensive loss and accumulated other comprehensive loss consists solely of cumulative currency translation adjustments resulting from the translation of the financial statements of its foreign subsidiary. The investment in this subsidiary is considered indefinitely invested overseas, and as a result, deferred income taxes are not recorded related to the currency translation adjustments.

Foreign Currency Translation/Transactions. Assets and liabilities of the Company’s non-U.S. subsidiary that operates in a local currency environment, where that local currency is the functional currency, are translated into U.S. dollars at exchange rates in effect at the balance sheet date and the resulting translation adjustments directly recorded to a separate component of accumulated other comprehensive loss. Income and expense accounts are translated at average exchange rates during the year. Transactional gains and losses from foreign currency transactions are recorded in other (income) expense, net.

income.

 

Segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance.  The Company further evaluates its operating segments to determine its reportable segments. Aemetis recognizes three reportable segments “California Ethanol”, “California Dairy Renewable Natural Gas”, and “India Biodiesel.”

 

The “California Ethanol” reportable segment includes the Company’s 65 million gallon per year Keyes plantPlant and the adjacent land leased for the production of CO₂.

 

The “California Dairy Renewable Natural Gas” reportable segment includes the dairy digesters, pipeline and gas condition hub for the production of biogasrenewable natural gas from dairies near Keyes, California.

 

14

(Tabular data in thousands, except par value and per share data)
 
 

The “India Biodiesel” reportable segment includes the Company’s 50 million gallon per year nameplate capacity biodiesel manufacturing Kakinada Plant, theand associate administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly.India.

 

The Company has additional operating segments that were determined not to be reportable segments, including the development of a Carbon Zero biofuels production plantsplant to produce renewable diesel and sustainable aviation fuel; the development of Carbon Capture and Sequestration compression system and injection wells;projects; a research and development facility in Minneapolis, Minnesota; and our corporate offices in Cupertino, California.

Fair Value of Financial Instruments. Financial instruments include accounts receivable, accounts payable, accrued liabilities, current and non-current portion of subordinated debt, notes receivable, notes payable, Series A preferred units, and long-term debt.  Due to the unique terms of our notes payable and long-term debt and the financial condition of the Company, the fair value of the debt is not readily determinable.  The fair value determined using level 3 inputs, of all other current financial instruments is estimated to approximate carrying value due to the short-term nature of these instruments.

Share-Based Compensation. The Company recognizes share-based compensation expense in accordance with ASC 718 Stock Compensation requiring the Company to recognize expenses related to the estimated fair value of the Company’s share-based compensation awards atcalculated as of the timedate the awards are granted, adjusted to reflect only those shares that are expected to vest.granted.

Commitments and Contingencies. The Company records and/or discloses commitments and contingencies in accordance with ASC 450 Contingencies. ASC 450 applies to an existing condition, situation or set of circumstances involving uncertainty as to possible loss that will ultimately be resolved when one or more future events occur or fail to occur.

 

Convertible Instruments. The Company evaluates the impacts of convertible instruments based on the underlying conversion features. Convertible instruments are evaluated for treatment as derivatives that could be bifurcated and recorded separately. Any beneficial conversion feature is recorded based on the intrinsic value difference at the commitment date.

 

Debt Modification Accounting. The Company evaluates amendments to its debt in accordance with ASC 470-60 Troubled Debt Restructuring and ASC 470-50 DebtModification and Extinguishments for modification and extinguishment accounting. The evaluation for troubled debt restructuring includes assessing qualitative and quantitative factors such as whether the creditor granted a concession and if the Company is experiencing financial difficulties. The quantitative analysis includes the calculation of the post-restructuring effective interest rate by projecting cash flows on the new terms and comparing this calculation to the terms of prior amendments. If the post restructuring effective interest rate is less than the prior terms effective interest rate, we assess this as having been granted a concession. The troubled debt restructuring accounting would be applied to any debt which meets the qualitative factors and quantitative factor of concession granted. If the debt would not fall into Troubled Debt Restructuring then we apply ASC 470-50 Debt-Modification and Extinguishment. This evaluation includes comparing the net present value of cash flows of the new debt to the old debt to determine if changes greater than 10 percent occurred. In instances where the net present value of future cash flows changed more than 10 percent, the Company applies extinguishment accounting and determines the fair value of its debt based on factors available to the Company.

 

For a complete summary of the Company’s significant accounting policies, please refer to the Company’s audited financial statements and notes thereto for the years ended December 31, 2022 and 2021 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 9, 2023.

 

2. Inventories

 

Inventories consist of the following:

 

 

As of

  

As of

 
 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Raw materials

 $6,947  $2,971  $3,705  $2,971 

Work-in-progress

 527  127  1,884  127 

Finished goods

  5,064   1,560   2,554   1,560 

Total inventories

 $12,538  $4,658  $8,143  $4,658 

 

As of March 31,September 30, 2023, and December 31,2022, the Company recognized a lower of cost or net realizable value impairment of $355of $298 thousand and none respectively, related to inventory.

 

15

(Tabular data in thousands, except par value and per share data)
 
 
 

3. Property, Plant and Equipment

 

Property, plant and equipment consist of the following:

 

 

As of

  

As of

 
 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Land

 $7,347  $7,344  $7,345  $7,344 

Plant and buildings

 137,558  99,116  140,951  99,172 

Furniture and fixtures

 1,927  1,831  2,028  1,831 

Machinery and equipment

 14,946  15,209  14,983  15,209 

Tenant improvements

 56  56 

Construction in progress

 52,573  88,934  59,919  88,934 

Property held for development

 15,431  15,437  15,437  15,437 

Finance lease right of use assets

  3,042   3,045   2,889   3,045 

Total gross property, plant & equipment

 232,880  230,972  243,552  230,972 

Less accumulated depreciation

  (52,072)  (50,531)  (55,476)  (50,531)

Total net property, plant & equipment

 $180,808  $180,441  $188,076  $180,441 

 

For the three months ended March 31,September 30, 2023 and 2022, interest capitalized in property, plant, and equipment was $1.8$1.5 million and $2.1$3.1 million, respectively. For the nine months ended September 30, 2023 and 2022, interest capitalized in property, plant, and equipment was $3.9 million and $7.7 million, respectively. 

 

Construction in progress includes costs for the biogas construction projects (dairy digesters and pipeline), Riverbank projects (sustainable aviation fuel and renewable diesel plant as well as carbon capture characterization well), and energy efficiency projects at the Keyes Plant. Depreciation on the components of property, plant and equipment is calculated using the straight-line method to allocate their depreciable amounts over their estimated useful lives as follows:

 

  

Years

 

Plant and buildings

  20 - 30 

Machinery and equipment

  5 - 15 

Furniture and fixtures

  3 - 5 

 

For the three months ended March 31, 2023 and 2022, the Company recorded depreciation expense of $1.8 million and $1.3 million, respectively. 

16

(Tabular data in thousands, except par value and per share data)
 
 
 

4. Debt

 

Debt consists of the following:

 

 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Third Eye Capital term notes

 $7,173  $7,141  $7,149  $7,141 

Third Eye Capital revolving credit facility

  65,558  60,602  26,756  60,602 

Third Eye Capital revolving notes Series B

 51,319 - 

Third Eye Capital revenue participation term notes

  11,995  11,963  11,985  11,963 

Third Eye Capital acquisition term notes

  26,625  26,578  26,607  26,578 

Third Eye Capital Fuels Revolving Line

  29,087  27,410  34,442  27,410 

Third Eye Capital Carbon Revolving Line

  23,135  22,710  23,554  22,710 

Construction Loan

  21,728 19,820  33,139  19,820 

Cilion shareholder seller notes payable

  6,871  6,821  6,975  6,821 

Subordinated notes

  16,106  15,931  16,737  15,931 

EB-5 promissory notes

  41,603  41,404  42,019  41,404 

Term loans on capital expenditures

  5,856  5,860  5,852  5,860 

Secured Loans

  3,535 - 

Working capital loans

  2,663  - 

Total debt

  261,935  246,240  286,534  246,240 

Less current portion of debt

  62,701   49,219   66,485   49,219 

Total long term debt

 $199,234  $197,021  $220,049  $197,021 

 

Third Eye Capital Note Purchase Agreement

 

On July 6, 2012, Aemetis, Inc. and Aemetis Advanced Fuels Keyes, Inc. (“AAFK”), entered into an Amended and Restated Note Purchase Agreement (the “Note Purchase Agreement”) with Third Eye Capital Corporation (“Third Eye Capital”). Pursuant to the Note Purchase Agreement, Third Eye Capital extended credit in the form of (i) senior secured term loans in an aggregate principal amount of approximately $7.2 million to replace existing notes held by Third Eye Capital (the “Term Notes”); (ii) senior secured revolving loans in an aggregate principal amount of $18.0 million (the “Revolving Credit Facility”); (iii) senior secured term loans in the principal amount of $10.0 million to convert the prior revenue participation agreement to a note (the “Revenue Participation Term Notes”); and (iv) senior secured term loans in an aggregate principal amount of $15.0 million (the “Acquisition Term Notes”) used to fund the cash portion of the acquisition of Cilion, Inc. (the Term Notes, Revolving Credit Facility, Revenue Participation Term Notes and Acquisition Term Notes are referred to herein collectively as the “Original Third Eye Capital Notes”).

 

17

(Tabular data in thousands, except par value and per share data)
 
 

On March 8, 2022, Third Eye Capital agreed to the Limited Waiver and Amendment No. 22 to the Note Purchase Agreement (“Amendment No. 22”) to: (i) provide a waiver for the Blocked Account Agreement Violation in which the Borrowers failed to deliver Blocked Account Control Agreements by December 31, 2021, (ii) provide for a waiver for the Subordinated Debt Violation, in which the Company made a repayment to a Subordinated Debt lender, and (iii) provide for a waiver of the consolidated unfunded capital expenditures covenant for the quarters through December 31, 2021.  As consideration for such waivers, the borrowers also agreed to pay Third Eye Capital an amendment and waiver fee of $0.1 million in cash.

 

On May 11, 2022, Third Eye Capital agreed to the Limited Waiver and Amendment No. 23 to the Note Purchase Agreement (“Amendment No. 23”) to: (i) provide a waiver for the Blocked Account Agreement Violation in which the Borrowers failed to deliver Blocked Account Control Agreements by March 31, 2022, (ii) provide for a waiver of the ratio of note indebtedness covenant for the quarter ended March 31, 2023 and (iii) provide for a waiver of the unfunded capital expenditures covenant for the quarter ended March 31, 2022 in which the Company exceeded the $100,000 capital expenditures limit. As consideration for such amendment and waivers, the borrowers also agreed to pay Third Eye Capital an amendment and waiver fee of $0.1 million.

 

On August 8th, 2022, Third Eye Capital agreed to Limited Waiver and Amendment No. 24 to the Note Purchase Agreement ("Amendment No. 24") to: (i) provide that the maturity date of the Third Eye Capital Notes may be further extended at our election to April 1, 2024 in exchange for an extension fee equal to 1% of the Note Indebtedness in respect to each Note, provided that such fee may be added to the outstanding principal balance of each Note on the effective date of each such extension, and (ii) provide for a waiver for certain covenant defaults. As consideration for such amendment and waivers, the borrowers also agreed to pay Third Eye Capital an amendment and waiver fee of $0.3 million in cash (the "Amendment No. 24 Fee").

 

On March 6, 2023, Third Eye Capital agreed to the Limited Waiver and Amendment No. 25 to the Note Purchase Agreement (“Amendment No. 25”) to: provide a waiver for the Keyes Plant Minimum Quarterly Production violation for the quarter ended March 31, 2023, in which the Borrowers will not meet the minimum production of 10 million gallons requirement. As consideration for such waivers, the borrowers also agreed to pay Third Eye Capital an amendment and waiver fee of $0.1 million.

 

On May 4, 2023, Third Eye Capital agreed to the Limited Waiver and Amendment No. 26 to the Note Purchase Agreement (“Amendment No. 26”) to: provide a waiver for (i) the Keyes Plant Minimum Quarterly Production violation for the quarter ended June 30, 2023, in which the Borrowers will not meet the minimum production of 10 million gallons requirement and (ii) the lender agrees to waive the cash payment of certain fees which are required by the Third Eye Capital Notes and allowed these fees to be added to the outstanding balance of the Revolving Notes. As consideration for such waivers, the borrowers also agreed to pay Third Eye Capital an amendment and waiver fee of $0.1 million. We evaluated the terms of Amendment No.26 and the maturity date extension in accordance with ASC 470-50 Debt – Modification and Extinguishment and ASC 470-60 Troubled Debt Restructuring and applied modification accounting treatment.

On May 16, 2023, Third Eye Capital agreed to the Limited Waiver and Amendment No.27 to the Note Purchase Agreement (“Amendment No.27”) to: (i) provide that the maturity date of the Third Eye Capital Notes may be further extended at our election to April 1, 2025 in exchange for an extension fee equal to 1% of the Note Indebtedness in respect to each Note, provided that such fee may be added to the outstanding principal balance of each Note on the effective date of each such extension, (ii) create a new series of Revolving Notes ("Revolving Notes Series B"), and (iii) provide for the issuance of new Revolving Notes Series B to provide for emergency funding. As consideration for such waivers, the borrowers also agreed to pay Third Eye Capital an amendment fee of $0.5 million, by adding the balance to the Revolving Notes Series B and issued a warrant exercisable for 80,000 shares of the Company's common stock were issued with an exercise price of $2.00 per each share issuable under the warrant. We evaluated the terms of Amendment No.27 in accordance with ASC 470-50 Debt – Modification and Extinguishment and ASC 470-60 Troubled Debt Restructuring and applied modification accounting treatment.

 

According to ASC 470-10-45 Debt–Other Presentation Matters, if it is probable that the Company will not be able to cure the default at measurement dates within the next 12 months, the related debt needs to be classified as current. To assess this guidance, the Company performed ratio and cash flow analysis using its cash flow forecast and debt levels for plant to debt ratio covenant and obtained waivers for the minimum ethanol production covenant for Q1’23 and Q2'23 in Amendments No. 25 and No. 26. The Company forecasted sufficient cash flows over the next 12 months to reduce debt levels of Third Eye Capital and meet the operations of the Company. Based on this analysis, the Company believes that it is reasonably possible that through a combination of cash flows from operations, sales from EB-5 investments, and proceeds from the sale of common stock, it will be able to meet the ratio of the note indebtedness covenant over the next 12 months. As such, the notes are classified as long-term debt.

 

On March 6, 2020, we and a subsidiary entered into a one-year reserve liquidity facility governed by a promissory note, payable to Third Eye Capital, in the principal amount of $18 million. On March 14, 2021, Third Eye Capital agreed to increase the amount available under the reserve liquidity facility to $70.0 million. Interest on borrowed amounts accrues at a rate of 30% per annum, paid monthly in arrears and may be capitalized and due upon maturity, or 40% if an event of default has occurred and continues. The outstanding principal balance of the indebtedness evidenced by the promissory note, plus any accrued but unpaid interest and any other sums due thereunder, shall be due and payable in full at the earlier to occur of (a) receipt by the Company or its affiliates of proceeds from any sale, merger, equity or debt financing, refinancing or other similar transaction from any third party and (b) April 1, 2023. Any amounts may be re-borrowed up to repaid amounts up until the maturity date of April 1, 2023. The promissory note is secured by liens and security interests upon the property and assets of the Company. In return, the Company will pay a non-refundable standby fee at 2% per annum of the difference between the aggregate principal amount outstanding and the commitment, payable monthly in cash. In addition, if any initial advances are drawn under the facility, the Company will pay a non-refundable one-time fee in the amount of $0.5 million provided that such fee may be added to the principal amount of the promissory note on the date of such initial advance. On August 9, 2021, Third Eye Capital agreed to decrease the amount available under the reserve liquidity notes governed by a promissory note to $40.0 million. On March 6, 2023, Third Eye Capital agreed to increase the reserve liquidity facility to $50 million and extend this for one year to April 1, 2024.

 

18

(Tabular data in thousands, except par value and per share data)
 
 

Terms of Third Eye Capital Notes

 

A.

Term Notes.  As of March 31,September 30, 2023, the Company had $7.2 million in principal and interest outstanding under the Term Notes and $70$52 thousand unamortized debt issuance costs. The Term Notes accrue interest at 14% per annum. The Term Notes mature on April 1, 2024.2024*.

 

B.

Revolving Credit Facility. The Revolving Credit Facility accrues interest at the prime rate plus 13.75% (21.75%(22.00% as of March 31,September 30, 2023) payable monthly in arrears. The Revolving Credit Facility matures on April 1, 2024.2024*. As of March 31,September 30, 2023, AAFK had $67.0$27.9 million in principal and interest and waiver fees outstanding and $1.5$1.1 million unamortized debt issuance costs under the Revolving Credit Facility.

 

C.

Revolving Notes Series B. The Revolving Notes Series B accrues interest at the prime rate plus 13.75% (22.00% as of September 30, 2023) payable monthly in arrears. The Revolving Notes Series B matures on April 1, 2024*. As of September 30, 2023, AAFK had $51.8 million in principal and interest and waiver fees outstanding and $0.4 million unamortized debt issuance costs under the Revolving Notes Series B.

C.D.

Revenue Participation Term Notes. The Revenue Participation Term Note bears interest at 5% per annum and matures on April 1, 2024.2024*. As of March 31,September 30, 2023, AAFK had $12.2$12.1 million in principal and interest outstanding under the Revenue Participation Term Notes and $160$106 thousand unamortized debt issuance costs.

 

D.E.

Acquisition Term Notes. The Acquisition Term Notes accrue interest at the prime rate plus 10.75% (18.75%(19.00% per annum as of March 31,September 30, 2023) and mature on April 1, 2024.2024*. As of March 31,September 30, 2023, Aemetis Facility Keyes, Inc. had $26.9 million in principal and interest and redemption fees outstanding under the AcquistionAcquisition Term Notes and $300$222 thousand unamortized debt issuance costs. The outstanding principal balance includes a total of $7.5 million in redemption fee on which interest is not charged.

 

E.F.

Reserve Liquidity Notes. The Reserve Liquidity Notes, with available borrowing capacity in the amount of $50.0 million, accrues interest at the rate of 30% per annum and are due and payable upon the earlier of: (i) the closing of new debt or equity financings, (ii) receipt from any sale, merger, debt or equity financing, or (iii) April 1, 2024. We have no borrowings outstanding under the Reserve Liquidity Notes as of March 31,September 30, 2023.

The note maturity dates marked with an "*" can be extended by the Company to April 2025. As a condition to any such extension, the Company would be required to pay a fee of 1% of the carrying value of the debt outstanding under the applicable notes of which 50% can be paid in cash or common stock (if paid through common stock it would be equivalent to 110% of the relevant half of such extension fee) and 50% can be added to the outstanding debt. As a result of this ability to extend the maturity at the Company’s will, the Third Eye Capital Notes are classified as non-current debt.

 

The Third Eye Capital Notes contain various covenants, including but not limited to, debt to plant value ratio, minimum production requirements, and restrictions on capital expenditures. The terms of the Third Eye Capital Notes allow the lender to accelerate the maturity in the occurrence of any event that could reasonably be expected to have a material adverse effect on the Company, such as any change in the business, operations, or financial condition. The Company has evaluated the likelihood of such an acceleration event and determined such an event to not be probable in the next twelve months. The terms of the notes allow interest to be capitalized.

 

The Third Eye Capital Notes are secured by first priority liens on all real and personal property of, and assignment of proceeds from all government grants and guarantees from the Company’s North American subsidiaries. The Third Eye Capital Notes all contain cross-collateral and cross-default provisions. McAfee Capital, LLC (“McAfee Capital”), owned by Eric McAfee, the Company’s Chairman and CEO, provided a guaranty of payment and performance secured by all of its Company shares. In addition, Eric McAfee provided a blanket lien on substantially all of his personal assets, and McAfee Capital provided a guarantee in the amount of $8.0 million.

 

19

(Tabular data in thousands, except par value and per share data)
 
 

Third Eye Capital Revolving Credit Facility for Fuels and Carbon Lines. On March 2, 2022, GAFI and Aemetis Carbon Capture, Inc. (“ACCI”) entered into an Amended and Restated Credit Agreement (“Credit Agreement”) with Third Eye Capital , as administrative agent and collateral agent, and the lender party thereto (the “New Credit Facility”). The New Credit Facility provides for two credit facilities with aggregate availability of up to $100 million, consisting of a revolving credit facility with GAFI for up to $50 million (the “Fuels Revolving Line”) and a revolving credit facility with ACCI for up to $50 million (the “Carbon Revolving Line” and together with the Fuels Revolving Line, the “Revolving Lines”). The revolving loans made under the Fuels Revolving Line have a maturity date of March 1, 2025 and will accrue a rate of interest per annum equal to the greater of (i) the prime rate plus 6.00% and (ii) ten percent (10.0%), and the revolving loans made under the Carbon Revolving Line will have a maturity date of March 1, 2026 and accrue a rate of interest per annum equal to the greater of (i) the prime rate plus 4.00% and (ii) eight percent (8.0%). The revolving loans made under the Fuels Revolving Line are available for working capital purposes and the revolving loans made under the Carbon Revolving Line are available for projects that reduce, capture, use or sequester carbon with the objective of reducing carbon dioxide emissions. In connection with the New Credit Facility, the Company agreed to issue to the lender under the New Credit Facility: (i) warrants entitling the lender to purchase 50,000 shares of common stock of the Company at an exercise price equal to $10.20 per share, exercisable for a five-year period from March 2, 2022; and (ii) warrants entitling holders thereof to purchase 250,000 shares of common stock of the Company, at an exercise price equal to $20.00 per share, exercisable for a ten-year period from March 2, 2022. In addition, under the Fuels Revolving Line, we issued 100,000 shares of common stock to existing note holders under the GAFI note purchase agreement. The shares were accounted at fair value and are being amortized over the life of the Fuels Revolving Line. Upon closing of the New Credit Facility, the Company drew on the revolving lines to repay $16.0 million on the higher interest rate AAFK Revolving Credit Facility, $6.1 million in property taxes, and to fund the capital projects and working capital projects.

 

On August 1, 2023, Third Eye Capital agreed to the Amendment and Waiver No.2 to Credit Agreement ("Amendment No.2") to: (i) approve a special advance of $2.3 million, which will constitute an overadvance, in order to pay and satisfy outstanding fees and obligations under the Credit Agreement; provided, that, such overadvance and prior outstanding overadvances under the Credit Agreement are repaid by the earlier of August 31, 2023 and an occurrence of certain mandatory repayment event; (ii) waive certain interest payment and fee violations under the Credit Agreement; and (iii) waive certain working capital violations and amend the related financial covenants in the Credit Agreement. As a consideration for such consents and waivers, the borrowers agreed to pay Third Eye Capital an amendment and waiver fee of $0.1 million.

On October 16, 2023, Third Eye Capital acknowledged receipt of $8.6 million repayment for the Revolving Credit facility under the July 2012 Note Purchase Agreement and $11.6 million repayment on the GAFI Credit Agreement.  As part of this acknowledgement, the available credit on the GAFI loan was raised to $37.5 million and the warrant issuable accordingly raised by 25,000 shares.

As of March 31,September 30, 2023, GAFI had principal and interest outstanding of $4.8$11.0 million classified as current debt and $26.1$25.0 million classified as long-term debt and $1.9$1.6 million unamortized debt issuance costs. As of March 31,September 30, 2023, ACCI had principal and interest outstanding of $0.5 million classified as current debt and $24.9 million classified as long-term debt and $2.2$1.9 million in unamortized debt issuance costs. TheThe current portion of the Revolving Lines are part of a $6.7$8.1 million specific advance between Third Eye Capital and the Company and certain accrued interests on the Fuel and Carbon revolving facilities that have been agreedrepaid on October 16, 2023. The special advance had been utilized by the Company to be repaid by July 31, 2023. pay the interest on notes and certain fees on notes and some expenses of the Company. As part of this arrangement, the Company issued a warrant exercisable for 80,000 shares of the Company's common stock with an exercise price of $2.00, to Third Eye Capital. As of March 31,September 30, 2023  there was no credit available under the Fuels and Carbon revolving facilities. Based on the repayments acknowledged by Third Eye Capital on October 16, 2023, we have an additional $1.4 million ofthe available borrowings under this advance agreement.credit on the Fuels Revolving facility with GAFI was $12.5 million.

 

Cilion shareholder seller notes payable. In connection with the Company’s merger with Cilion, Inc. (“Cilion”), on July 6, 2012, the Company issued $5.0 million in notes payable to Cilion shareholders as merger compensation subordinated to the senior secured Third Eye Capital Notes. The liability bears interest at 3% per annum and is due and payable after the Third Eye Capital Notes have been paid in full. As of March 31,September 30, 2023, Aemetis Facility Keyes, Inc. had $6.9 $7.0 million in principal and interest outstanding under the Cilion shareholder seller notes payable.

 

Subordinated Notes. On January 6 and January 9, 2012, AAFK entered into Note and Warrant Purchase Agreements with two accredited investors pursuant to which it issued $0.9 million and $2.5 million in original notes to the investors (“Subordinated Notes”). The Subordinated Notes mature every six months. Upon maturity, the Subordinated Notes are renewable at the Company's election for six month periods with a fee of 10% added to the balance outstanding plus issuance of warrants exercisable at $0.01 with a two-year term. Interest accrues at 10% per annum and is due at maturity. Neither AAFK nor Aemetis may make any principal payments under the Subordinated Notes until all loans made by Third Eye Capital to AAFK are paid in full.

 

On  JanuaryJuly 1, 2023, the maturity on two Subordinated Notes’ was extended until the earlier of (i) June 30,December 31, 2023; (ii) after the occurrence of an Event of Default, including failure to pay interest or principal when due and breaches of note covenants. A $90 thousand and $250 thousand cash extension fee was paid by adding the fee to the balance of the new Subordinated Notes and 113 thousand common stock warrants were granted with a term of two years and an exercise price of $0.01 per share.

 

20

(Tabular data in thousands, except par value and per share data)
 
 

The Company evaluated the January 1, 2023 and July 1, 2023 amendments and the refinancing terms of the notes and applied modification accounting treatment in accordance with ASC 470-50 Debt – Modification and Extinguishment.

 

At March 31,September 30, 2023 and December 31, 2022, the Company had, in aggregate, the amount of $16.1$16.7 million and $15.9 million in principal and interest outstanding, respectively, under the Subordinated Notes.

 

EB-5 promissory notes. EB-5 is a U.S. government program authorized by the Immigration and Nationality Act designed to foster employment-based visa preference for immigrant investors to encourage the flow of capital into the U.S. economy and to promote employment of U.S. workers. The Company entered into a Note Purchase Agreement dated March 4, 2011 (as further amended on January 19, 2012 and July 24, 2012) with Advanced BioEnergy, LP, a California limited partnership authorized as a “Regional Center” to receive EB-5 investments, for the issuance of up to 72 subordinated convertible promissory notes (the “EB-5 Notes”) bearing interest at 2-3%. Each note was issued in the principal amount of $0.5 million and due and payable four years from the date of each note, for a total aggregate principal amount of up to $36.0 million (the “EB-5 Phase I funding”). The original maturity date on the promissory notes can be extended automatically for a one- or two-year period initially and is eligible for further one-year automatic extensions as long as there is no notice of non-extension from investors and the investors’ immigration process is in progress. On February 27, 2019, Advanced BioEnergy, LP, and the Company entered into an Amendment to the EB-5 Notes which restated the original maturity date on the promissory notes with automatic six-month extensions as long as the investors’ immigration processes are in progress. Except for six early investor EB-5 Notes, the Company was granted 12 months from the date of the completion of immigration process to redeem these EB-5 Notes. Given the COVID-19 pandemic and processing delays for immigration process, Advanced BioEnergy, LP extended the maturity dates for debt repayment based on their projected processing timings as long as the investors do not give notice of withdrawal or an I-829 gets approved. Accordingly, the notes have been recognized as long-term debt while investor notes who obtained green card approval have been classified as current debt. The EB-5 Notes are convertible after three years at a conversion price of $30 per share.  

 

The Company has sold an aggregate principal amount of $36.0 million of EB-5 Notes under the EB-5 Phase I funding since 2012 to the date of this filing. As of March 31,September 30, 2023, $35.5 million has been released from the escrow amount to the Company, with $0.5 million remaining to be funded to escrow. As of March 31,September 30, 2023 and December 31, 2022, $37.4$37.7 million and $37.2 million waswas outstanding, respectively, on the EB-5 Notes sold under the EB-5 Phase I funding.funding.

 

On October 16, 2016, the Company launched its EB-5 Phase II funding (the “EB-5 Phase II Funding”), with plans to issue $50.0 million in additional EB-5 Notes on substantially similar terms and conditions as those issued under the Company’s EB-5 Phase I funding, to refinance indebtedness and capital expenditures of Aemetis, Inc. and Goodland Advanced Fuels Inc., (“GAFI”). On November 21, 2019, the minimum investment was raised from $0.5 million per investor to $0.9 million per investor. The Company entered into a Note Purchase Agreement dated with Advanced BioEnergy II, LP, a California limited partnership authorized as a Regional Center to receive EB-5 Phase II funding investments, for the issuance of up to 100 EB-5 Notes bearing interest at 3%. On May 1, 2020 Supplement No. 3 amended the offering documents and lowered the total eligible new EB-5 Phase II funding investors to 60. Eight EB-5 investors have funded at the $0.5 million per investor amount, with 52 new EB-5 Phase II funding investors remaining eligible at the new $0.9 million per investors amount under the current offering. Job creation studies show it may be possible to add additional investors and increase the total offering amount in the future. Each EB-5 note will be issued in the principal amount and due and payable five years from the date of each EB-5 note, for a total aggregate principal amount of up to $50.8 million.

 

The Company has sold an aggregate principal amountamount of $4.0 million of EB-5 Notes under the EB-5 Phase II funding since 2016 to the date of this filing. As of March 31,September 30, 2023, $4.0 million has been released from escrow to the Company and $46.8$46.5 million remains to be funded to escrow. As of March 31,September 30, 2023, and December 31, 2022, $4.3 million and $4.2 million waswere outstanding on the EB-5 Notes under the EB-5 Phase II funding.funding, respectively.-n

 

21

(Tabular data in thousands, except par value and per share data)
 
 

Working capital loans. On July 26, 2022, the Company entered into a short-term loan with Secunderabad Oils Limited in an amount not to exceed $1.88 million. On August 1, 2022, the Company entered into a short-term loan with Leo Edibles & Fats Limited in an amount not to exceed $1.27 million. The loans bears interest at 18% and are payable monthly.  The loans are repayable on demand by the lender or within one year from the date of issuance. As of March 31,September 30, 2023 and December 31, 2022, the Company had $2.7 million and no balance under these agreements.

 

Secured loans. In the first quarter ofof 2023, the Company entered into several short-term loans with IndusInd Bank and HDFC Bank. The loans are secured by fixed deposits made by the Company. The loans bear interest at rates that range from 6% to 8%.  The loans mature between November 15, 2023 and May 3, 2024. As of March 31,September 30, 2023 and December 31, 2022, the Company had $3.5 million and no balance, respectively, under these agreements.

 

Construction Loan Agreement. On October 4, 2022, the Company entered into a Construction Loan Agreement (“Loan Agreement”) with Greater Nevada Credit Union (“GNCU”). Pursuant to the Loan Agreement, the lender has made available an aggregate principal amount not to exceed $25 million. The loan is secured by all personal property collateral and real property collateral of the Aemetis Biogas 1 LLC. The loan bears interest at a rate of 5.95% per annum and has an USDA annual renewal fee of 0.25%, with interest only payments to be paid in monthly installments, and a maturity date of MarchDecember 4, 2023, at which time the entire unpaid principal amount, together with accrued and unpaid interest, is expected to be repaid from the proceeds of a term loan this is 80% USDA guaranteed and issued by GNCU pursuant to a USDA Conditional Commitment. The Loan Agreement contains certain financial covenants to be measured as of the last day of each fiscal year beginning fiscal year end 2023, and annually for the term of the loan. The Loan Agreement also contains other affirmative and negative covenants, representations and warranties and events of default customary for loan agreements of this nature. As of March 31,September 30, 2023 and December 31, 2022, the Company haCompand $21.7y had $23.9 million and $20.2 million, respectively, outstanding and unamortized discount issuances costs of none and $0.3 million, respectively, under the Loan Agreement. 

 

On March 4, July 28, 2023,GNCU agreed to the First Amendment to Promissory NoteCompany entered into a second Construction and Term Loan Agreement (“Loan Agreement 2") with Magnolia Bank, Incorporated. Pursuant to the Loan Agreement 2, the lender has made available an aggregate principal amount notto extendexceed $25 million. The loan is secured by all personal property collateral and real property collateral of Aemetis Biogas 2 LLC. The loan bears interest at a rate of 8.75% per annum, to be adjusted every five years thereafter to equal thefive-year Treasury Constant Maturity Rate, as published by the Board of Governors of the Federal Reserve System as of the adjustment date, plus 5.00%. Other material terms of the Loan include: (i) payments of interest only to be paid in monthly installments beginning August 15, 2023, (ii) payments of equal combined monthly installments of principal and interest beginning on August 15, 2025, and (iii) a maturity date of July 28, 2043, at which time the entire unpaid principal amount, together with accrued and unpaid interest thereon, shall become due and payable. The AB2 Term Loan contains certain financial covenants to be measured as of the last day of each fiscal year beginning fiscal year end 2024, and annually for the term of the loan. The AB2 Loan Agreement also contains other affirmative and negative covenants, representations and warranties and events of default customary for loan agreements of this nature. As of September 30, 2023 and December 31, 2022, the Company had $10.0 million and none, respectively, outstanding and unamortized discount issuances costs of  $0.8 million and none, respectively, under the Loan Agreement to August 1, 2023 and increase the interest rate to 9.0%.  As consideration for the amendment, the borrowers agreed to pay GNCU a lenders fee and expenses of $9 thousand. We analyzed the agreement according to ASC 470-602. Troubled Debt Restructuring and we determined that GNCU provided a concession when comparing the initial credit agreement with a lower interest rate and higher fees to the new debt amendment with a higher interest rate and lower fees. In accordance with the provisions of ASC 470-60 Troubled Debt Restructuring, we applied troubled debt restructuring accounting, resulting in no gain or loss from the application of this accounting.

 

Financing Agreement for capital expenditures. The Company entered into an agreement with Mitsubishi Chemical America, Inc. (“Mitsubishi”) to purchase ZEBREXTM membrane dehydration equipment to conserve energy and improve operating efficiencies at the Keyes Plant. The Company also entered into a financing agreement with Mitsubishi for $5.7 million for this equipment. Payments pursuant to the financing transaction will commence after the installation date and interest will be charged based on the certain performance metrics after operation of the equipment. We recorded the asset in property, plant and equipment, net and recorded the related liability of $1.2 $1.7 million in short term borrowings and $4.6$4.1 million in other long-term debt, respectively as of March 31,September 30, 2023.

Scheduled debt repayments for the Company’s loan obligations by year are as follows:

 

Twelve Months ended March 31,

 

Debt Repayments

 

Twelve Months ended September 30,

 

Debt Repayments

 

2024

 $62,701  $66,485 

2025

 171,981  182,609 

2026

 28,894  29,448 

2027

 2,861  4,266 

2028

  978   1,531 

Thereafter

  650   8,403 

Total debt

 268,065  292,742 

Debt issuance costs

  (6,130)  (6,208)

Total debt, net of debt issuance costs

 $261,935  $286,534 

 

 

5. Commitments and Contingencies

 

Leases

 

We have identified assets as the corporate office, warehouse, monitoring equipment and laboratory facilities over which we have control and obtain economic benefits fully. Wefully and classified these identified assets as operating leases after assessing thethe terms under classification guidance. We have entered into several leases for trailers and carbon units with purchase option at the end of the term. We have concluded that it is reasonably certain that we would exercise the purchase option at the end of the term, hence the leases were classified as finance leases. All of our leases have remaining term of less than a yeartwo years to 15fourteen years.

 

We made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet. We will recognize those lease payments in the Consolidated Statements of Operations as we incur the expenses.

 

When discount rates implicit in leases cannot be readily determined, the Company uses the applicable incremental borrowing rate at lease commencement to perform lease classification tests on lease components and measure lease liabilities and right-of-use (“ROU”) assets. The incremental borrowing rate used by the Company was based on weighted average baseline rates commensurate with the Company’s secured borrowing rate over a similar term. At each reporting period, when there is a new lease initiated, the rates established for that quarter will be used.

 

22

(Tabular data in thousands, except par value and per share data)
 
 

On December 14, 2021, we entered into a real estate purchase agreements and lease disposition and development agreement with the City of Riverbank. We plan to utilize the purchased and leased properties, located at 5300 Claus Road in the city of Riverbank, California, for the construction of the Carbon Zero Facility. The lease commenced on April 1, 2022. The Company evaluated the lease in accordance with ASC 842 – Lease Accounting and classified the lease as a finance lease.

 

The components of lease expense and sublease income were as follows:

 

 

Three months ended March 31,

  

Three months ended September 30,

  

Nine months ended September 30,

 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Operating lease cost

            

Operating lease expense

 $181  $189  $180  $159  $542  $506 

Short term lease expense

 21  27  89  44  131  146 

Variable lease expense

  22   23   26   23   70   68 

Total operating lease cost

 $224  $239  $295  $226  $743  $720 
  

Finance lease cost

            

Amortization of right-of-use assets

 $31  $63  $30  $26  $91  $115 

Interest on lease liabilities

  91   19   83   98   256   217 

Total finance lease cost

 $122  $82  $113  $124  $347  $332 

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

Three months ended March 31,

  

Three months ended September 30,

  

Nine months ended September 30,

 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Operating cash flows used in operating leases

 $164  $164  $169  $184  $499  $522 

Operating cash flows used in finance leases

 91  19  83  98  256  216 

Financing cash flows used in finance leases

 $83  $132  $83  $132  $394  $314 

 

Supplemental non-cash flow information related to ROU asset and lease liabilities was as follows for the three and ninemonths ended March 31,September 30, 2023 and 2022:

 

  

Three months ended March 31,

 
  

2023

  

2022

 

Operating lease cost

        

Operating lease expense

 $181  $189 

Short term lease expense

  21   27 

Variable lease expense

  22   23 

Total operating lease cost

 $224  $239 
         

Finance lease cost

        

Amortization of right-of-use assets

 $31  $63 

Interest on lease liabilities

  91   19 

Total finance lease cost

 $122  $82 
  

Three months ended September 30,

  

Nine months ended September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Operating leases

                

Accretion of the lease liability

 $81  $83  $252  $262 

Amortization of right-of-use assets

  100   76   291   244 
                 

The weighted average remaining lease term and weighted average discount rate as of September 30, 2023 are as follows:

                
                 

Weighted Average Remaining Lease Term

                

Operating leases (in years)

  4.5             

Finance leases (in years)

  13.3             
                 

Weighted Average Discount Rate

                

Operating leases

  14.1%            

Finance leases

  13.2%            

 

23

(Tabular data in thousands, except par value and per share data)
 
 

Supplemental balance sheet information related to leases was as follows:

 

 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Operating leases

        

Operating lease right-of-use assets

 $2,355  $2,449  $2,159  $2,449 
  

Current portion of operating lease liability

 355  338  390  338 

Long term operating lease liability

  2,095   2,189   1,890   2,189 

Total operating lease liabilities

  2,450   2,527   2,280   2,527 
  

Finance leases

        

Property and equipment, at cost

 $3,045  $3,045  $2,889  $3,045 

Accumulated depreciation

  (143)  (112)  (198)  (112)

Property and equipment, net

  2,902   2,933   2,691   2,933 
  

Other current liability

 (5) 71  -  71 

Other long term liabilities

  2,994   2,911   2,666   2,911 

Total finance lease liabilities

  2,989   2,982   2,666   2,982 

 

Maturities of operating lease liabilities were as follows:

 

Twelve months ended March 31,

 

Operating leases

  

Finance leases

 

Twelve months ended September 30,

 

Operating leases

  

Finance leases

 
  

2024

 $672  $354  $680  $204 

2025

 679  179  672  176 

2026

 670  159  648  145 

2027

 631  145  641  145 

2028

  650   145   436   145 

Thereafter

  110   11,000   -   10,105 

Total lease payments

 3,412  11,982  3,077  10,920 

Less imputed interest

  (962)  (8,993)  (797)  (8,254)

Total lease liability

 $2,450  $2,989  $2,280  $2,666 

 

The Company acts as sublessor in certain leasing arrangements, primarily related to land and buildings.  Fixed sublease payments received are recognized on a straight-line basis over the sublease term. Sublease income and head lease expense for these transactions are recognized on a gross basis on the consolidated financial statements. This was recorded in the Selling, general and administrative expense section of the Consolidated Statements of Operations and Comprehensive Loss.

 

The components of lease income for the three months ended March 31, 2023 and March 31, 2022were as follows:

 

  

March 31, 2023

  

March 31, 2022

 

Lease income

 $471  $- 

  

Three months ended September 30,

  

Nine months ended September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Lease income

 $230  $429  $1,182  $429 
 

Future lease commitments to be received by the Company as of March 31,September 30, 2023 were as follows:

 

Twelve months ended March 31,

    

Twelve months ended September 30,

    

2024

 $811  $806 

2025

 560  729 

2026

 482  569 

2027

 474  474 

2028

  474   474 

Thereafter

  947   711 

Total future lease commitments

 $3,748  $3,763 

 

24

(Tabular data in thousands, except par value and per share data)
 
 

Property taxes

On March 3, 2022, the Company paid $6.1 million to Stanislaus County for property taxes past due.


Legal Proceedings

 

The Company is subject to legal proceedings and claims which arise in the ordinary course of its business. While the ultimate outcome of these matters is not presently determinable, it is in the opinion of management that the resolution of outstanding claims will not have a material adverse effect on the financial position or results of operations of the Company. The Company's view of the matters not listed may change in the future as the litigation and events related thereto unfold.

 

 

6. Aemetis Biogas LLC Series A Preferred Financing and Variable Interest Entity

 

On December 20, 2018, ABGL entered into a Series A Preferred Unit Purchase Agreement for the sale of Series A Preferred Units to Protair-X Americas, Inc., with Third Eye Capital acting as an agent.

 

ABGL is authorized to issue 11,000,000 common units, and up to 6,000,000 convertible, redeemable, secured, preferred membership units (the “Series A Preferred Units”). ABGL issued 6,000,000 common units to the Company at $5.00 per common unit for a total of $30,000,000 in funding. Additionally, 5,000,000 common units of ABGL are held in reserve as potential conversion units issuable to the Purchaser upon certain triggering events discussed below.

 

The Preferred Unit Agreement includes (i) preference payments of $0.50 per unit on the outstanding Series A Preferred Units commencing on the second anniversary, with any outstanding preference payments shall have an interest per annum rate equal to ten percent (ii) conversion rights for up to 1,200,000 common units or up to maximum number of 5,000,000 common units (also at a one Series A Preferred Unit to one common unit basis) if certain triggering events occur, (iv) one board seat of the three available to be elected by Series A Preferred Unit holders, (iii) mandatory redemption value at $15 per unit payable at an amount equal to 75% of free cash flow generated by ABGL, up to $90 million in the aggregate (if all units are issued), (iv) full redemption of the units on the sixth anniversary, (v) minimum cash flow requirements from each digester, and (vi) $0.9 million paid as fees to the Agent from the proceeds. Until paid, the obligations of ABGL under the Preferred Unit Agreement are secured by the assets of ABGL in an amount not to exceed the sum of (i) $30,000,000, plus (ii) all interest, fees, charges, expenses, reimbursement obligations and indemnification obligations of ABGL.

 

Triggering events occur upon ABGL’s failure to redeem units, comply with covenants, any other defaults or cross defaults, or to perform representations or warranties. Upon a triggering event: (i) the obligation of the Purchaser to purchase additional Series A Preferred Units is terminated, (ii) cash flow payments for redemption payments increases from 75% to 100% of free cash flows, and (iii) total number of common units into which preferred units may be converted increases from 1,200,000 common units to 5,000,000 common units on a one for one basis. As of March 31,September 30, 2023, ABGL has not generated minimum quarterly operating cash flows by operating the dairies. As a result of the violation of this covenant, free cash flows, when they occur, may be applied for redemption payments at the increased rate of 100% instead of the initial rate of 75% of free cash flows.

 

From inception of the agreement to date, ABGL issued 3,200,000 Series A Preferred Units on first tranche for a value of $16.0 million and also issued 2,800,000 of Series A Preferred Units on second tranche for a value of $14.0 million, reduced by a redemption of 20,000 Series A Preferred Units for $0.3 million. The Company identified freestanding future tranche rights and the accelerated redemption feature related to a change in control provision as derivatives whichthat required bifurcation. These derivative features were assessed to have minimal value as of March 31,September 30, 2023 and December 31, 2022 based on the evaluation of the other conditions included in the agreement.

 

On August 8, 2022, ABGL, Protair-X America, Inc. (“Protair”), and Third Eye Capital entered into a Waiver and Amendment to Series A Preferred Unit Purchase Agreement (“PUPA Amendment") which amends that certain Series A Preferred Unit Purchase Agreement (“PUPA”) dated as of December 20, 2018. The PUPA Amendment provides for: (i) a waiver of certain covenants prohibiting the internal reorganization of ABGL subsidiaries and the incurrence of indebtedness by ABGL and its subsidiaries pursuant to a USDA loan, provided that, among other things, Third Eye Capital shall have received a repayment of at least $7.3 million to be applied to the Carbon Revolving Line contemporaneously with the closing of the Construction Loan Agreement; (ii) a waiver of certain operational defaults under the PUPA; and (iii) an amendment which (a) requires ABGL to redeem all of the outstanding Series A Preferred Units by December 31, 2022 (the “Final Redemption Date”) for $116 million; and (b) provides ABGL the right to redeem all of the outstanding Series A Preferred Units by September 30, 2022 for $106 million. The PUPA Amendment further provides the failure to redeem the Series A Preferred Units by the Final Redemption Date would constitute a triggering event requiring ABGL to enter into a credit agreement with Protair and Third Eye Capital effective as of January 1, 2023. We evaluated the terms of the PUPA Amendment and applied extinguishment accounting treatment in accordance with ASC 470-50 Debt – Modification and Extinguishment and recorded a loss on extinguishment of $49.4 million in the third quarter of 2022.

 

25

(Tabular data in thousands, except par value and per share data)
 
 

On January 1, 2023, ABGL entered into the Second Waiver and Amendment to Series A Preferred Unit Purchase Agreement (“PUPA Second Amendment") providing for: (i) a waiver for not complying to redeemredeeming all Series A Preferred Units by December 31, 2022, and (ii) provides ABGL the right by ABGL to redeem all of the outstanding Series A Preferred Units by May 31, 2023 for an aggregate redemption price of $125 million. The PUPA Second Amendment further provides that failure to redeem the Series A Preferred Units by the redemption date, ABGL is required to enter into a credit agreement with Protair and Third Eye Capital effective as of June 1, 2023 and maturing on May 31, 2024, in substantially the form attached to the PUPA Second Amendment. We determined that Third Eye Capital provided a concession to redeem the preferred shares at lower effective borrowing rate than the credit agreement interest rate or prior amendment rate. In accordance with the provisions of ASC 470-60 Troubled Debt Restructuring, we applied troubled debt restructuring accounting, resulting in no gain or loss from the application of this accounting. In addition, given that the Company could turn the agreement into a credit agreement, the Company is accreting these tranches from an initial carrying value at December 31, 2022 of $116.0 million to $159.0 million over the seventeen months ending May 31, 2024. 

On May 31, 2023, ABGL entered into the Third Waiver and Amendment to Series A Preferred Unit Purchase Agreement (“PUPA Third Amendment") providing: (i) a waiver to ABGL for not redeeming all Series A Preferred Units by May 31,2023 and (ii) the right by ABGL to redeem all of the outstanding Series A Preferred Units by August 31,2023, for an aggregate redemption price of $135 million. The PUPA Third Amendment further provides that failure to redeem the Series A Preferred Units by the redemption date, ABGL is required to enter into a credit agreement with Protair and Third Eye Capital effective, as of September 1,2023 and maturing on August 31,2024, in substantially the form attached to the PUPA Third Amendment. We determined that Third Eye Capital provided a concession to redeem the preferred shares at lower effective borrowing rate than the credit agreement interest rate or prior amendment rate. In accordance with the provisions of ASC 470-60 Troubled Debt Restructuring, we applied troubled debt restructuring accounting, resulting in no gain or loss from the application of this accounting In addition, given that the Company could turn the agreement into a credit agreement, the Company is accreting these tranches from a carrying value at May 31,2023 of $127.2 million to $171.7 million over the fifteen months ending August 31,2024.Hence, the preferred redemption balance is classified as long term liability as of March 31,September 30, 2023.

 

On November 8, 2023, ABGL entered into a Fourth Waiver and Amendment to Series A Preferred Unit Purchase Agreement (“PUPA Fourth Amendment") with Third Eye Capital Corporation and Protair-X Americas, Inc. providing for: (i) extending the deadline to redeem Series A Preferred Units from August 31, 2023 to December 31, 2023 and (ii) setting the price to redeem all outstanding Series A Preferred Units at $102.5 million plus a closing fee of $5,500,000, payable to or at the direction of Protair-X Americas, Inc. The PUPA Fourth Amendment further provides that if ABGL does not redeem the Series A Preferred Units by December 31, 2023, ABGL will enter into a credit agreement with Third Eye Capital Corporation and Protair-X Americas, Inc. effective as of January 1, 2024, in substantially the form attached to the PUPA Fourth Amendment. The PUPA Fourth Amendment is attached to this Form 10-Q as Exhibit 10.1.  We will evaluate the terms of the PUPA Fourth Amendment in accordance with ASC 470.

The Company recorded Series A Preferred Unit liabilities, net of debt discounts pursuant to these agreements, classified as long-term Series A Preferred Units, of $122.5 million$137.8 million and $116.0 million as of March 31,September 30, 2023 and December 31, 2022, respectively.

 

Variable interest entity assessment

 

After consideration of ABGL’s operations and the above agreement, we concluded that ABGL did not have enough equity to finance its activities without additional subordinated financial support. ABGL is capitalized with Series A Preferred Units that are recorded as liabilities under U.S. GAAP. Hence, we concluded that ABGL is a VIE. Through the Company's ownership interest in all of the outstanding common stock, its current ability to control the board of directors, the management fee paid to Aemetis and control of subordinated financing decisions, Aemetis has been determined to be the primary beneficiary and accordingly, the assets, liabilities, and operations of ABGL are consolidated into those of the Company. Total assets, before intercompany eliminations, of ABGL as of March 31,September 30, 2023 were $78.8 $141.4 million whichwhich serve as collateral for the Series A Preferred Units. The Series A Preferred Units are not collateralized by any other assets or guarantees from Aemetis or its subsidiaries.

 

7. Stock-Based Compensation

 

2019 Stock Plan

 

On April 29, 2019, theThe Aemetis Amended and Restated 2019 Stock Plan (the “2019 Stock Plan”) was approved by stockholders ofallows the Company. This plan permits theCompany to grant of Incentive Stock Options, Non-Statutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares and other stock or cash awards as the AdministratorCompany’s Board may determine in its discretion.  The 2019 Stock Plan’s term is 10 years and supersedes all prior plans. The 2019 Stock Plan authorizedOption grants made under the issuance of 200,000 shares of common stock for the 2019 calendar year, in addition to permitting transferring and granting any available and unissued or expired options under theSecond Amended and Restated 2007 Stock  Plan in an amount upprior to 177,246 shares of common stock.

With the approvaladoption of the 2019 Stock Plan the Zymetis 2006 Stock Plan, and Amended and Restated 2007 Stock Plan (collectively, the “Stock Plans”) were terminatedremain in place according to their terms.  The number of shares authorized for granting any optionsissuance under either plan. However, any options granted before the 2019 Stock Plan approved will remain outstanding and can beincreases on January 1 of each year according to the terms of the plan.  In addition, shares associated with stock options that expire or are forfeited without being exercised and any expired options will bebecome available to grant under the 2019 Stock Plan.again for issuance.

 

26

(Tabular data in thousands, except par value and per share data)
 
 

CommonThe following table summarizes activity under the 2019 Stock Reserved for IssuancePlan and prior plan during the nine-month period ending September 30, 2023:

  

Shares Available for Grant

  

Number of Shares Outstanding

  

Weighted-Average Exercise Price

 

Balance as of December 31, 2022

  65

*

  4,694  $4.63 

Authorized

  1,644   -   - 

Options Granted

  (1,278)  1,278   3.60 

RSAs Granted

  (244)  -   - 

Exercised

  -   (141)  1.63 

Forfeited/expired

  221   (221)  5.58 

Balance as of September 30, 2023

  408   5,610  $4.43 

 

The following is a summarynumber of awards granted under the Stock Plans:

  

Shares Available for Grant

  

Number of Shares Outstanding

  

Weighted-Average Exercise Price

 

Balance as of December 31, 2022

  165   4,694  $4.63 

Authorized

  1,435   -   - 

Options Granted

  (1,178)  1,178   3.75 

RSAs Granted

  (244)  -   - 

Exercised

  -   (40)  0.69 

Forfeited/expired

  62   (62)  4.31 

Balance as of March 31, 2023

  240   5,770  $4.48 

Asoutstanding option shares as of March 31,September 30, 2023, there were 3.4includes 3.8 million options vested under the Stock Plans.shares that are vested.

 

Stock-based compensation*The 2015 Employment Inducement Stock Plan (the “2015 Inducement Plan”) authorizes issuance of options for 100 thousand shares of common stock to new employees, which are not included in the above table.  As of September 30, 2023, there are no option grants outstanding under the 2015 Inducement Plan.

Valuation and Expense Recorded for Stock Option Issuances

 

Stock-based compensation is accounted for in accordance with the provisions of ASC 718 Compensation-Stock Compensation, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method.

Valuation and Expense Information


All issuances of stock options or other issuances of equity instruments to employees as the consideration for services received by us are accounted for based on the fair value of the equity instrument issued. The fair value of options granted to employees is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock based compensation expense requires us to make assumptions and judgments about the variables used in the calculation, including the fair value of our common stock, the expected term (the period of time that the options granted are expected to be outstanding), the volatility of our common stock, a risk-free interest rate, and expected dividends. Under ASU 2016-09 Improvements to Employee Share-Based Payments Accounting, we have elected to recognize forfeitures as they occur. We use the simplified calculation of expected life described in the SEC’s Staff Accounting Bulletin No. 107, Share-Based Payment, and volatility is based on an average of the historical volatilities of the common stock of four entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. We use an expected dividend yield of zero, as we do not anticipate paying any dividends in the foreseeable future. Expected forfeitures are assumed to be zero due to the small number of plan participants.

 

During the three months ended March 31, 2023 and 2022, the Company granted 1.2 million and 0.9 million options, respectively. The weighted average fair value calculations for the options granted during these periodsthe nine months ended 2023 and 2022 are based on the following assumptions:

 

 

For the three months ended March 31, 2023

  

For the nine months ended September 30,

 

Description

 

2023

  

2022

  

2023

  

2022

 

Dividend-yield

 -% -% -  - 

Risk-free interest rate

 3.82% 1.66% 3.86% 2.03%

Expected volatility

 125.32% 113.45% 124.62% 117.21%

Expected life (years)

 7.00  7.00  7.00  7.00 

Market value per share on grant date

 $3.75  $11.31  $3.60  $10.97 

Fair value per option on grant date

 $3.43  $9.89  $3.29  $9.71 

 

During the threenine months ended March 31,September 30, 2023 and 2022, the Company granted 243,850 and 60,300 restricted stock awards, respectively, with a fair value on date of grant of $3.75$3.60 and $11.31,$13.75, respectively, per award.share.

 

27

(Tabular data in thousands, except par value and per share data)
 
 

As of March 31,September 30, 2023, the Company had $12.8had $8.9 million of total unrecognized compensation expense for employees,option issuance, which the Company will amortize over the 2.1 years ofremaining vesting period for each applicable grant, which has a weighted average remaining term.of 1.7 as of September 30, 2023.

 

 

8. Outstanding Warrants

During the three months ending September 30, 2023, the Company granted warrants to subordinated lenders in connection with debt extensions.  The warrants were exercisable for 113,000 shares of the Company's common stock at an exercise price of $.01 per share with a two-year term.  These warrants were also exercised during the three months ending September 30, 2023.

 

The weighted average fair value calculations for issued warrants granted are based on the following weighted average assumptions:factors:

 

 

For the three months ended March 31, 2023

  

For the nine months ended September 30,

 

Description

 

2023

  

2022

  

2023

  

2022

 

Dividend-yield

 -% -% -% -%

Risk-free interest rate

 4.41% 1.45% 3.80% 1.75%

Expected volatility

 125.32% 139.55% 117.60% 151.41%

Expected life (years)

 2.00  4.00  4.63  3.52 

Exercise price per warrant

 $0.01  $13.33  $1.18  $10.47 

Market value per share on grant date

 $3.96  $13.06  $4.11  $11.29 

Fair value per warrant on grant date

 $3.95  $11.01  $3.97  $9.68 

 

A summary of historicalThe following table summarizes warrant activity follows:during the nine months ending September 30, 2023:

 

 

Warrants Outstanding & Exercisable

  

Weighted - Average Exercise Price

  

Average Remaining Term in Years

  

Warrants Outstanding & Exercisable

  

Weighted - Average Exercise Price

  

Average Remaining Term in Years

 

Outstanding December 31, 2022

  355  $15.92   7.48   355  $15.92   7.48 

Granted

 113  0.01     486  1.18    

Exercised

  (113)  0.01       (336)  0.83     

Outstanding March 31, 2023

  355  $15.92   7.24 

Outstanding September 30, 2023

  505  $11.78   6.15 

 

AllThe warrants outstanding as of the above outstanding warrantsSeptember 30, 2023 are vested and exercisable as of March 31, 2023September .30,2023. As of March 31,September 30, 2023 and 2022, the Company had no unrecognized compensation expense related to warrants, respectively.

  

 

9. Agreements

 

Working Capital Arrangement. Pursuant to a Corn Procurement and Working Capital Agreement with J.D. Heiskell, the Company agreed to procure whole yellow corn and grain sorghum, primarily from J.D. Heiskell. The Company has the ability to obtain grain from other sources subject to certain conditions; however, in the past all the Company’s grain purchases have been from J.D. Heiskell. Title and risk of loss of the corn pass to the Company when the corn is deposited into the Keyes Plant weigh bin. The term of the Corn Procurement and Working Capital Agreement expires on December 31, 2023, and the term can be automatically renewed for additional one-year terms. J.D. Heiskell further agreed to sell all ethanol to Murex or other marketing purchasers, all WDG continuesand corn oil to be sold to A.L.GilbertA.L Gilbert, and DCO is sold to other customers under the J.D. Heiskell Purchase Agreement. The Company’sCompany’s relationships with J.D. Heiskell, and A.L. Gilbert are well established, and the Company believes that the relationships are beneficial to all parties involved in utilizing the distribution logistics, reaching out to widespread customer base, managing inventory, and building working capital relationships. These agreementsAgreements are ordinary purchase and sale agency agreements for the Keyes Plant. On May 13, 2020,25, 2023, we entered into the second amendment to the Aemetis Keyes Grain Procurement and Working Capital agreement with J.D. Heiskell, the second amendment to the Corn Procurement and Working Capital Agreement with J.D. Heiskell, and the Company entered into Amendment No.1second amendment to the Keyes Ethanol and Corn Tank Lease with J.D. Heiskell. The amendments provide that (i) the Keyes Plant will receive a temporary increase in the credit limit equivalent to four days of grain payables repayable in equal daily installments over 120 days, (ii) that J.D. Heiskell Purchasing Agreementagrees to removebuy all Ethanol, WDGS, CDS, and Corn Oil produced by the Keyes Plant, sell all ethanol to certain designated purchasers and pay us the same price as it received from such sales, and (iii) J.D. Heiskell’s obligations to purchaseHeiskell would lease certain ethanol product storage tanks from the Company under the J.D. Heiskell Purchasing Agreement.Keyes Plant.

 

As of March 31,September 30, 2023 and December 31, 2022, Aemetis made prepayments to J.D. Heiskell of $0.4 millionnone and $2.4$2.4 million, respectively.

 

28

(Tabular data in thousands, except par value and per share data)
 

The J.D. Heiskell sales and purchases activity associated with the J.D. Heiskell Purchase Agreement and J.D. Heiskell Procurement Agreement during the three and ninemonths ended March 31,September 30, 2023 and 2022 were as follows:

 

 

As of and for the three months ended March 31,

  As of and for the three months ended September 30,  As of and for the nine months ended September 30, 
 

2023

 

2022

  

2023

  

2022

  

2023

  

2022

 

Ethanol Sales

 $36,375 $- $45,388 $- 

Wet distiller's grains sales

 $-  $11,517   9,427   13,003   11,980   39,669 

Corn oil sales

 37  2,338  1,487  2,917  1,613  8,067 

CDS Sales

 9 - 62 - 

Corn purchases

 302  44,009  37,030  53,063  48,029  151,425 

Accounts receivable

 -  116  1,008  106  1,008  106 

Accounts payable

 -  508 

Accounts Payable

 759  540  759  540 

Working Capital

 13 - 13 - 

 

Ethanol and Wet Distillers Grains Marketing Arrangement. The Company entered into a Fuel Ethanol Purchase and Sale Agreement with Murex, which matures on October 31, 2023, with automatic one-year renewals thereafter. On May 30, 2023 the Company entered into Amendment No.1 to the Fuel Ethanol Purchase and Sale Agreement that provides (i) the Company temporarily suspend the agreement for the duration of the Company's Working Capital Agreement with J.D. Heiskell, and (ii) the initial term shall be automatically renewed beginning on October 1, 2023 and ending on March 31, 2025. The Company also entered into a Wet Distillers Grains Marketing Agreement with A.L. Gilbert, which matures on December 31, 2023, with automatic one-year renewals thereafter.

 

Accounts receivable associated with our marketing partners was $0none and $0.6 million as of March 31,September 30, 2023 and December 31, 2022.

 

For the three months ended March 31,September 30, 2023 and 2022, the Company expensed marketing costs of $3.0 thousand $0.8 million and $0.8 million, respectively, and $700 thousand,for the nine months ended September 30, 2023 and 2022, the Company expensed marketing costs of$0.7 million and $2.2 million, respectively, under the terms of both the Ethanol Marketing Agreement and the Wet Distillers Grains Marketing Agreement. These marketing costs are presented as part of Selling, General, and Administration expense.

 

Supply Trade Agreement. On July 1, 2022, the Company entered into an operating agreement with Gemini Edibles and Fats India Private Limited (“Gemini”). Under this agreement, Gemini agreed to provide the Company with a supply of feedstock up to a credit limit of $12.7 million. If the Company fails to pay the invoice within the ten-day credit period, the outstanding amount will bear interest at 12%.  The term of the agreement is for one year. Either party can terminate the agreement by giving notice one month notice in writing. As of March 31,September 30, 2023 and December 31, 2022, the Company had accounts payable of $2.1$0.5 million and no outstanding balance,balance, respectively, under this agreement.

 

As of March 31,September 30, 2023 and 2022, the Company has no forward sales commitments.

 

 

10. Segment Information

 

Aemetis recognizes three reportable segments: “California Ethanol”, “California Dairy Renewable Natural Gas”, and “India Biodiesel.”

 

The “California Ethanol” reportable segment includes the Company’s 65 million gallon per year Keyes Plant, and the adjacent land leased for the production of CO₂.

 

The “California Dairy Renewable Natural Gas” reportable segment includes the dairy digesters, biogas pipeline, and gas conditionconditioning unit for the production of biogas from dairies near Keyes, California.renewable natural gas, and interconnection facility to PG&E’s pipeline.

 

The “India Biodiesel” reportable segment includes the Company’s 50 million gallon per year nameplate capacity biodiesel manufacturing Kakinada Plant and the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius.India. The Company’s biodiesel is marketed and sold primarily to customers in India through brokers and by the Company directly.

 

The Company has additional operating segments that were determined not to be reportable segments, including the development of the Carbon Zero facility in Riverbank, and thedevelopment of Carbon Capture projectand Sequestration projects in California.  Additionally, the corporate offices, Riverbank Industrial Complex, Goodland Plant in Kansas, and the research and development facility in Minnesota are included in the “All Other” category.

 

29

(Tabular data in thousands, except par value and per share data)
 

Summarized financial information by reportable segment for the three months ended March 31,September 30, 2023 and 2022 follows: 

 

 

For the three months ended March 31, 2023

  

For the three months ended September 30, 2023

 
 

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

  

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

 
  

Revenues from external customers

 $475  $206  $1,470  $-  $2,151 

Gross loss

 (12) (773) (510) -  (1,295)

Revenues

 $47,439  $1,107  $20,144  $-  $68,690 

Gross profit (loss)

 (1,473) (807) 2,772  -  492 
  

Interest expense including amortization of debt fees

 5,518  704  69  2,756  9,047  6,729  620  19  2,814  10,182 

Accretion and other expenses of Series A preferred units

 -  5,564  -  -  5,564  -  7,739  -  -  7,739 

Capital expenditures

 334  6,499  36  747  7,616  1,363  6,819  372  233  8,787 

Depreciation

 1,109  457  155  69  1,790  960  598  158  31  1,747 

 

 

For the three months ended March 31, 2022

  

For the three months ended September 30, 2022

 
 

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

  

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

 
  

Revenues from external customers

 $52,041  $-  $8  $-  $52,049  $60,908  $-  $10,923  $-  $71,831 

Intersegment revenues

 -  335  -  -  335  -  308  -  -  308 

Gross profit (loss)

 (2,880) (207) 8  (6) (3,085) (3,763) (179) 2,841  (3) (1,104)
  

Interest expense including amortization of debt fees

 5,645  4  -  612  6,261  4,744  7  69  2,275  7,095 

Accretion and other expenses of Series A preferred units

 -  1,640  -  -  1,640  -  2,774  -  -  2,774 

Capital expenditures

 1,803  5,449  67  2,140  9,459  210  3,626  -  2,577  6,413 

Depreciation

 1,011  146  168  11  1,336  1,023  156  161  38  1,378 

 

A reconciliation of reportable segment revenues to total consolidated revenue for the three months ended March 31,September 30, 2023 and 2022 follows:

 

 

2023

  

2022

  

2023

  

2022

 

Total revenues for reportable segments

 $2,151  $52,384  $68,690  $72,139 

Elimination of intersegment revenues

  -   (335)  -   (308)

Total consolidated revenues

 $2,151  $52,049  $68,690  $71,831 

Summarized financial information by reportable segment for the nine months ended September 30, 2023 and 2022 follows: 

  

For the nine months ended September 30, 2023

 
  

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

 
                     

Revenues

 $59,246  $1,523  $55,184  $-  $115,953 

Gross profit (loss)

  (3,807)  (2,644)  7,604   -   1,153 
                     

Interest expense including amortization of debt fees

  18,499   1,841   313   8,205   28,858 

Accretion and other expenses of Series A preferred units

  -   20,188   -   -   20,188 

Capital expenditures

  2,423   14,622   523   1,027   18,595 

Depreciation

  3,029   1,578   470   131   5,208 

  

For the nine months ended September 30, 2022

 
  

California Ethanol

  

California Dairy Renewable Natural Gas

  

India Biodiesel

  

All other

  

Total

 
                     

Revenues from external customers

 $178,840  $-  $10,941  $-  $189,781 

Intersegment revenues

  -   940   -   -   940 

Gross profit (loss)

  (6,795)  (454)  2,859   (13)  (4,403)
                     

Interest expense including amortization of debt fees

  15,258   12   69   4,679   20,018 

Accretion and other expenses of Series A preferred units

  -   5,920   -   -   5,920 

Capital expenditures

  7,379   15,771   136   5,645   28,931 

Depreciation

  3,011   456   493   79   4,039 

A reconciliation of reportable segment revenues to total consolidated revenue for the nine months ended September 30, 2023 and 2022 follows:

  

2023

  

2022

 

Total revenues for reportable segments

 $115,953  $190,721 

Elimination of intersegment revenues

  -   (940)

Total consolidated revenues

 $115,953  $189,781 

 

30

(Tabular data in thousands, except par value and per share data)
 

Total assets by reportable segments as of March 31,September 30, 2023 and December 31, 2022 follows:

 

 

March 31, 2023

 

December 31, 2022

 

September 30, 2023

  

December 31, 2022

 

California Ethanol

 

$ 62,508

 

$ 66,794

 $65,968  $66,794 

California Dairy Renewable Natural Gas

 

76,607

 

77,714

 138,597  77,714 

India Biodiesel

 

24,054

 

16,120

 23,576  16,120 

All other

 

47,212

 

46,486

  49,298   46,486 

Total consolidated assets

 

$ 210,381

 

$ 207,114

 $277,439  $207,114 

 

California Ethanol: The Company amended the Corn Procurement and Working Capital Agreement and the J.D. Heiskell Purchasing Agreement to procure corn from J.D. Heiskell and sell all WDG and corn oil the Company produces to J.D. Heiskell. Sales of ethanol to one customer accounted for 77%99.7% of the Company’s California Ethanol segment revenues for the three months ended March 31,September 30, 2023. Sales of ethanol, WDG, and corn oil to two customers accounted for 73% and 26% of the Company’s California Ethanol segment revenues for the three months ended September 30, 2022. Sales of ethanol, WDG, corn oil to one customer accounted for 99.7% of the Company’s California Ethanol segment revenues for the nine months ended September 30, 2023. Sales of ethanol, WDG, and corn oil to two customers accounted for 73% and 27% of the Company’sCompany’s California Ethanol segment revenues for the threenine months ended March 31,September 30, 2022.

 

California Dairy Renewable Natural Gas: 100% of ourOur California Dairy Renewable Natural Gas segment revenues during the three and ninemonths ended March 31,September 30, 2023 were from sales of biogas to one customer and sales of D3 RINs to a separate customer. For the three and ninemonths ended March 31,September 30, 2022, all sales were from sale of biogas to the Keyes Plant for useas fuel in boilers, which allowed qualification of carbon credits for the ethanol produced in the Keyes Plant.

 

India Biodiesel: One Three biodiesel customercustomers accounted for 80%42%, 35%, and 19% of the Company’s consolidated India segment revenues for the three months ended March 31,September 30, 2023. Three biodiesel customers accounted for 43%, 28% and 24% of the Company’s consolidated India segment revenues for the nine months ended September 30, 2023. Three biodiesel customers accounted for 52%, 23%, and 22% of the Company’s consolidated India segment revenues for the three and nine months ended September 30, 2023.

 

11. Related Party Transactions

 

TheThe Company owes Eric McAfee, the Company’s Chairman and CEO, and McAfee Capital LLC (“McAfee Capital”), owned by Eric McAfee,McAfee, $0.4 million in connectionconnection with employment agreements and expense reimbursements previously accrued as salaries expense and accrued liabilities. The Company previously prepaid $0.2 million to Redwood Capital, a company controlled by Eric McAfee, for the Company’s use of flight time on a corporate jet. As of March 31,September 30, 2023, $0.1 million remained as a prepaid expense.

On January 12, 2022, the Audit Committee of the Company approved a one-time guarantee fee of $2.0 million to McAfee Capital in connection with McAfee Capital’s extension of certain guarantees of the Company’s indebtedness with Third Eye Capital. The Company paid this fee by issuing 180,000 shares of common stock of the Company.

 

In the first quarter of 2023, the Audit Committee of the Company approved a one-time guarantee fee of $0.4 million to McAfee Capital in connection with McAfee Capital’s guarantees of the Company’s indebtedness with Third Eye Capital. As of March 31,September 30, 2023, $0.1 million has been accrued as the guarantee fee.outstanding balance is $0.2 million.

 

The Company owes various members of the Board amounts totaling $0.4 millionmillion and $0.3 million as of March 31,September 30, 2023 and December 31, 2022, in connection with board compensation fees, which are included in accounts payable on the balance sheet. For the three months ended March 31,September 30, 2023 and 2022, the Company expensedexpensed $0.1 million respectively,respectively, in connection with board compensation fees. For the nine months ended September 30, 2023 and 2022, the Company expensed $0.3 million respectively, in connection with board compensation fees.  

 

 

12. Subsequent Events

 

On May 4,October 6, 2023, the Company received the $55.2 million due to it from the sale of Investment Tax Credits.  On October 16, 2023, the Company paid $50.2 million of these funds to Third Eye Capital agreedas payments against existing debt obligations, including $8.6 million repayment for the Revolving Credit facility under the July 2012 Note Purchase Agreement, $11.6 million repayment on the GAFI Credit Agreement, and $30.0 million repayment on the Series A Preferred Unit Purchase Agreement.  In conjunction with the payment, the Company’s available credit on the GAFI loan has been raised to the Limited$37.5 million.

On November 8, 2023, ABGL entered into a Fourth Waiver and Amendment No.26to the NoteSeries A Preferred Unit Purchase Agreement (“Amendment No.26”PUPA Fourth Amendment") to: provide a waiver for (i) the Keyes Plant Minimum Quarterly Production violation for the quarter ended June 30,2023, in which the Borrowers will not meet the minimum production of 10 million gallons requirement and (ii) the lender agrees to waive the cash payment of certain fees which are required by thewith Third Eye Capital NotesCorporation and allowed these feesProtair-X Americas, Inc. providing for: (i) extending the deadline to be added redeem Series A Preferred Units from August 31, 2023 to December 31, 2023 and (ii) setting the price to redeem all outstanding balanceSeries A Preferred Units at $102.5 million plus a closing fee of $5,500,000, payable to or at the Revolving Notes. As consideration for such waivers,direction of Protair-X Americas, Inc. The PUPA Fourth Amendment further provides that if ABGL does not redeem the borrowers also agreed to paySeries A Preferred Units by December 31, 2023, ABGL will enter into a credit agreement with Third Eye Capital an amendmentCorporation and waiver feeProtair-X Americas, Inc. effective as of $0.1 million.January 1, 2024, in substantially the form attached to the PUPA Fourth Amendment.  The PUPA Fourth Amendment is attached to this Form 10-Q as Exhibit 10.1.  We will evaluate the terms of the PUPA Fourth Amendment in accordance with ASC 470.

 

13. Mangement'sManagement's Plan

 

The accompanying financial statements have been prepared contemplating the realization of assets and satisfaction of liabilities in the normal course of business. As a result of negative capital, negative market conditions resulting in prolonged idling of the Keyes Plant, negative operating results, and collateralization of substantially all of the company assets, the Company has been reliant on its senior secured lender to provide additional funding and has been required to remit substantially all excess cash from operations to the senior secured lender. In order to meet its obligations during the next twelve months, the Company will need to either refinance the Company’s debt or receive the continued cooperation of its senior lender. This dependence on the senior lender raises substantial doubt about the Company’s ability to continue as a going concern. The Company plans to pursue the following strategies to improve the course of the business.

 

For the Keyes Plant, we plan to restartrestarted the plant during the second quarter now that theafter completing an extended maintenance cycle is complete,and accelerating the implementation of several important ethanol plant energy efficiency upgrades. We plan to operate the plant and continue to improve its financial performance by completing the existing upgrades and adopting new technologies or process changes that allow for energy efficiency, cost reduction or revenue enhancements, as well as, executeexecuting upon awarded grants that improve energy and operational efficiencies resulting in lower cost, lower carbon demands and overall margin improvement.

 

31

(Tabular data in thousands, except par value and per share data)
 

For Aemetis Biogas we plan to operate the biogas digesters to capture and monetize biogas as well as continue to build new dairy digesters and extend the existing pipeline in order to capture the higher carbon credits available in California. Funding for continued construction is based upon obtaining government guaranteed loans and executing on existing and new state grant programs.

For the Riverbank project, we plan to raise the funds necessary to construct and operate the Carbon Zero plant in Riverbank, CA using loan guarantees and public financings based upon the licensed technology that generate federal and state carbon credits available for ultra-low carbon fuels utilizing lower cost, non-food advanced feedstocks to significantly increase margins.

For all facilities in the United States, we plan to utilize the provision of the Inflation Reduction Act of 2022 by qualifying for renewable energy credits, whether in the form of an Investment Tax Credit, Producers Tax Credit or other credits and monetize the credits using the provisions of this congressional act.

 

For the Kakinada Plant, we plan to continue to develop sales channels for domestic products as the costs of feedstock normalize against the price of diesel, as recently announced governmental incentives take effect to promote the blending of biodiesel, and as feedstocks such as refined animal tallow are used domestically and exported. Additionally, we are in the process of obtaining approval to export refined animal tallow and biodiesel produced using animal tallow into international markets as the use of refined animal tallow received approval from the Pollution Control Board of India for production of biodiesel. The repatriation of funds from India to the parent company in the U.S. is reliant on favorable governmental approvals. 

For the Riverbank project, we plan to continue project development and raise the funds necessary to construct and operate the Carbon Zero plant in Riverbank, California to produce renewable diesel and sustainable aviation fuel for transportation use as well as generate federal and state carbon credits available for the production and sale of low carbon fuels.

For all facilities in the United States, we plan to utilize the provision of the Inflation Reduction Act of 2022 by qualifying for tax credits in the form of an Investment Tax Credits, Production Tax Credits, and other credits, and to monetize the credits using the provisions of this congressional act.

 

In addition to the above we plan to continue to locate funding for existing and new business opportunities through a combination of working with our senior lender, restructuring existing loan agreements, selling bonds in the taxable and tax-exempt markets, selling equity through the ATM and otherwise, selling the current EB-5 Phase II offering, or by vendor financing arrangements.

 

32

(Tabular data in thousands, except par value and per share data)
 
 

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

 

Our Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is provided in addition to the accompanying consolidated condensed financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. MD&A is organized as follows:

 

 

Overview. Discussion of our business and overall analysis of financial and other highlights affecting us, to provide context for the remainder of MD&A.

 

 

Results of Operations. An analysis of our financial results comparing the three and nine months ended March 31,September 30, 2023 and 2022.

 

 

Liquidity and Capital Resources. An analysis of changes in our balance sheets and cash flows and discussion of our financial condition.

 

 

Critical Accounting Policies and Estimates. Accounting policies and estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results and forecasts.

 

The following discussion should be read in conjunction with our consolidated condensed financial statements and accompanying notes included elsewhere in this report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Report, particularly under Part II, Item 1A. Risk Factors, and in other reports we file with the SEC. All references to years relate to the calendar year ended December 31 of the particular year.

 

Overview

 

Founded in 2006 and headquartered in Cupertino, California, Aemetis Inc. (collectively with its subsidiaries on a consolidated basis referred to herein as “Aemetis,” the “Company,” “we,” “our” or “us”) is an international renewable natural gas and renewable fuels company focused on the acquisition, development and commercialization of innovative low and negative carbon intensity products and technologies that replace traditional petroleum-based products. We operate in three reportable segments consisting of “California Ethanol,” “California Dairy Renewable Natural Gas,” and “India Biodiesel.” We have other operating segments determined not to be reportable segments and are collectively represented by the “All Other” category. At Aemetis, ourOur mission is to generate sustainable and innovative renewable fuel solutions that benefit communities and restore our environment. We do this by building a local circular bioeconomy utilizing agricultural and waste to produce low-carbon,low and negative carbon, advanced renewable fuels that reduce greenhouse gas (“GHG”) emissions and improve air quality by replacing traditional petroleum-based products. 

 

Our California Ethanol segment consists of a 65 million gallon per year capacity ethanol production facility located in Keyes, California (the “Keyes Plant”) that we own and operate. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains (“WDG”), Distillers Corn Oil (“DCO”), Carbon Dioxide (“CO2”) and Condensed Distillers Solubles (“CDS”), all of which are sold as animal feed to more than 80 local dairies and feedlots, with CO₂ sold to food, beverage, and industrial customers. We haveare implementing several energy efficiency initiatives focused on significantly lowering the carbon intensity of our fuels,ethanol, primarily by decreasing our use of petroleum-based natural gas.gas at the Keyes plant. These energy efficiency projects include:include high efficiency heat exchangers; the Mitsubishi ZEBREXTM ethanol dehydration system; a two-megawatt solar microgrid with battery storage; thean Allen Bradley Decision Control System (DCS) to manage and optimize energy use and other plant operations; and thea Mechanical Vapor Recompression (MVR) system to reuse steam. These projects are expected to reduce petroleum natural gas use by converting key Keyes Plant processes to use electricity rather than natural gas and powering systemsby using low-carbon-intensity hydroelectric electricity or electricity produced onsite from solar panels.

In the third quarter of 2022, we completed the installation and began the operation of the ZEBREXTM ethanol dehydration system at the Keyes Plant, a key first step in the electrification of the Keyes Plant, that is expected to significantly reduce the use of petroleum-based natural gas as process energy at the plant. The electrification, along with the future installation of the two-megawatt zero carbon intensity solar microgrid system and the mechanical vapor recompression (MVR) system, This will significantly reduce GHG emissions from the production facility and decrease the carbon intensity (CI) of fuel produced at the Keyes Plant.  The lower CI of ethanol produced at the Keyes Plant will allow us to realize a higher price for the ethanol produced and sold at the Keyes Plant.

During the last two weeks of December 2022, we undertook an extended maintenance cycle and accelerated the implementation of several importantthe ethanol plant energy efficiency plant upgrades noted above. Our decision was partly driven by the high natural gas prices in Northern California during the period. Furthermore, after monitoring natural gas pricing and margin profitability, we decided to extend the maintenance cycle throughinto the end of the firstsecond quarter of 2023. As such, revenues fromWith natural gas pricing in a reasonable range and the Keyes Plant duringmaintenance turn-around complete, we restarted the firstplant in the second quarter of 2023 were limited to sales of stored inventory at the plant.2023.

 

Our California Dairy Renewable Natural gas segment which consistsbuilt, operates, and is actively expanding a network of our subsidiary Aemetis Biogas LLC, "Aemetis Biogas" or “ABGL,” constructs and operates bio-methane anaerobic digesters at local dairies near the Keyes Plant (many of whom also purchase WDG produced by the Keyes Plant as animal feed); transports the biogas viaby pipeline to an upgrading up located at the Keyes Plant site; converts the biogas to Renewable Natural Gas (“RNG”), which is then delivered; and delivers the RNG to customers through the PG&E natural gas pipeline.

The Aemetis Biogas network includes the Aemetis Biogas Central Dairy Project, which operates 40 miles of completed biogas pipeline; six operating dairy digesters; five dairy digesters that are under construction; a centralized biogas-to-RNG conversion facility located at the Keyes Plant site; and a renewable natural gas interconnection with the PG&E utility gas pipeline. A total of 30 dairies have signed contracts with Aemetis Biogas in connection with participation in the Aemetis Biogas Central Dairy Project. 

The dairy digesters are connected via an underground private pipeline owned by ABGL to a gas cleanup and compression unit at the Keyes Plant to produce dairy RNG. Upon receiving the bio-methane from the dairies, impurities are removed, and the bio-methane is converted to negative carbon intensity RNG that is injected into the statewide PG&E gas utility pipeline for use as transportation fuel or used as renewable process energy at the Keyes Plant.

33

(Tabular data in thousands, except par value and per share data)

 

Our India Biodiesel segment owns and operates a plant in Kakinada, India (“Kakinada Plant”) with a nameplate capacity of 150 thousand metric tons per year, or about 50 million gallons per year, producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. We believe the Kakinada Plant is one of the largest biodiesel production facilities in India on a nameplate capacity basis. The Kakinada Plant is capable of processing a variety of vegetable oils and animal fat waste feedstocks into biodiesel that meets international product standards. Our Kakinada Plant can also distill the crude glycerin byproduct from the biodiesel refining process into refined glycerin, which is sold to the pharmaceutical, personal care, paint, adhesive, and other industries.

 

Our All Other segment consists of: the development of our Carbon Zero biofuels production plantsplant to produce renewable diesel and sustainable aviation fuel; the development of our Carbon Capture and Sequestration compression system and injection wells; operation of the Riverbank Industrial Complex; a research and development facility in Minneapolis, Minnesota; and our corporate offices in Cupertino, California.

 

33

(Tabular data in thousands, except par value and per share data)

Our Carbon Zero biofuels production plants areplant is designed to produce low or negative carbon intensity sustainable aviation fuel (“SAF”) and renewable diesel fuel (“RD”) utilizingusing low carbon hydroelectric electricity, renewable hydrogen and non-edible renewable oils sourced from existing Aemetis biofuels plants and other sources. TheOur first Carbon Zero plant is scheduled to be built in Riverbank, California at the 125-acre former Riverbank Army ammunition plant.  The Riverbank plant is expected to utilize zero carbon hydroelectric and other renewable power available onsite to produce 90 million gallons per year of SAF RD, and other byproducts.RD. The plant is expected to supply the aviation and truck markets with ultra-lowlow carbon renewable fuels to reduce GHG emissions and other pollutants associated with conventional petroleum-based fuels. By producing ultra-lowlow carbon renewable fuels, the Company expects to capture high value D3will generate Renewable Identification Numbers (“RINs”) under the federal Renewable Fuel Standard (“RFS”), generate California Low Carbon Fuel Standard (“LCFS”) credits, and produce Inflation Reduction Act tax credits.

 

Our Carbon Capture subsidiary was established to build Carbon Capture and Sequestration (“CCS”) projects that generate LCFS and IRS 45Q tax credits by compressing and injecting CO₂ into deep wells whichthat are monitored for emissions to ensure the long-term sequestration of carbon underground. California’s Central Valley has been identified as one of the world’s most favorable regions for large-scale CO₂ injection projects due to the subsurface geologic formation that absorbs and retains CO₂ gas. The two initial Aemetis CCS injection projects are expected to capture and sequester more than two million metric tons per year of CO₂ at the Aemetis biofuels plant sites in Keyes and Riverbank, California. In July 2022, Aemetis purchased 24 acres located onat the Riverbank Industrial Complex site in Riverbank, California to develop a CCS injection well with more than 1 million metric tonnestons per year of CO₂ sequestration capacity. The Company plansWe plan to construct a characterization well at each site to obtain soilcharacterize the geology to provide information for permitting as required forand planning the EPA Class VI CO₂ injection well permit application.projects.

 

Our Minneapolis, Minnesota research and development laboratory develops efficient conversion technologies using low carbon intensity and waste feedstocks to produce low or below zero carbon intensity biofuels and biochemicals. We are focused on processes that extract sugar from cellulosic feedstocks and then utilize the remaining biomass to produce low carbon renewable hydrogen for the production of sustainable aviation fuel, renewable diesel and potential sale of renewable hydrogen to third parties as transportation fuel.

 

California Ethanol Revenue

 

Revenue generation for our California Ethanol segment relies upon supplying ethanol into the transportation fuel market in Northern California and supplying feed products to dairy and other animal feed operations in Northern California. We are actively implementing plans that will bring higher value for our fuel ethanol in an effort to improve our overall margins and to add incremental income to the California Ethanol segment, including, the implementation of the Solar Microgrid System, the installation of the Zebrex ethanol dehydration system, the installation of mechanical vapor recompression, and other energy efficiency technologies. The energy efficiency upgrades to the Keyes Plant will result in higher LCFS value through the reduction of the carbon intensity of the fuel ethanol produced at the plant. On December 22, 2022, the Keyes Plant entered an extended maintenance cycle and accelerate the implementation of several important ethanol energy efficiency plant upgrades. With natural gas pricing in a reasonable range and the maintenance turn-around complete, we expect to restart the plant during the second quarter of 2023.

 

EthanolWe sell all ethanol, WDG, CDO, and CDS produced in this process to J.D. Heiskell. Our ethanol finished goods tank is sold directlyleased by J.D. Heiskell and legal title to our fuel marketing partner Murex LLC (“Murex”). We own the ethanol stored inproduct is transferred upon transfer of our finished goods tank. WDG are soldethanol to A.L. Gilbert and DCO is sold to other customers under the J.D. Heiskell Purchase Agreement. Smaller amounts of CDS are sold to various local third parties.this location. The CO₂ produced by the Keyes Plant is sold to Messer Gas. 

 

34

(Tabular data in thousands, except par value and per share data)

 

California Ethanol revenue is dependent on the price of ethanol, WDG, CDS, CO₂, and DCO. Ethanol pricing is influenced by local and national production and inventory levels, imported ethanol, corn prices, and gasoline demand, and is determined pursuant to a marketing agreement with a single fuel marketing customer and is generally based on daily and monthly pricing for ethanol delivered to the San Francisco Bay Area, California, as published by Oil Price Information Service (“OPIS”), as well as quarterly contracts negotiated by our marketing company with local fuel blenders. The price for WDG is influenced by the price of corn, the supply and price of distillers dried grains, and demand from the local dairy and feed markets and determined monthly pursuant to a marketing agreement with A.L. Gilbert and is generally determined in reference to the local price of dried distillers’ grains and other comparable feed products. Our revenue is further influenced by the price of natural gas, and our decision to operate the Keyes Plant at various capacity levels, conduct required maintenance, and respond to biological processes affecting output.

 

California Dairy Renewable Natural Gas Revenue

 

InSince December 2018, we have utilized our relationships with California’s Central Valley dairy farmers by signing leases and raising funds to construct dairy digesters, a 40-mile pipeline, and a biogas-to-RNG upgrading facility that delivers RNG to deliver fuels for sale toa utility gas pipeline. We are currently producing RNG from sixseven digesters connected by our pipeline then flowing this gas to our RNG cleanup and compression hub at the Keyes Plant. The RNG upgrade unit at the Keyes Plant enables the production and delivery of utility-grade RNG for sale as transportation fuel to California customers via the PG&E pipeline delivery interconnection.

In addition to the existing and operating dairy digesters, we currently have five additional dairy digesters that are under construction. We have a total of approximately 30 signed34 agreements with dairies to construct dairy digesters. Our revenue development strategy for the Dairy Renewable Natural Gas segment relies upon continuing to collect bio-methane gas from the existing dairy digesters, continuing to build out the network of dairy digesters, extending the pipeline to grow the supply of RNG available forfor sale, and utilizing the biogas-to-RNG upgrade unit to distribute utility-grade RNG to customers statewide. We are currently storing the produced RNG until the LCFS CI pathway for each dairy has been approved, after which we will sell the stored gas to transportation customers statewide.

 

Inflation Reduction Act of 2022

 

For all facilities in the United States, we plan to utilizecontinue to use the provisionprovisions of the Inflation Reduction Act of 2022 by qualifying for renewable energy credits whether in the form of an Investment Tax Credit, ProducersCredits, Production Tax Credit, orand other credits, and to monetize the credits using the provisions of this congressional act.

 

India Biodiesel Revenue

 

Our revenue strategy in India is based on continuing to sell biodiesel to our bulk fuel customers, fuel station customers, mining customers, industrial customers and tender offers placed by GovernmentGovernment-owned Oil Marketing Companies (“OMCs”) for bulk purchases of fuels. Recently,During the first quarter, the government of India updated the national biofuels policy and adopted a new tax on diesel fuel to promote biodiesel blending.  As a result, the OMCs are pricing the tenders at economically viable levels, allowing for biodiesel producers in India to begin production.

 

During the secondthird quarter of 2023, we receivedfulfilled an OMC's tenderOMC tender offer for 31,697 kiloliters (approximately 27,41817,066 metric tons),tons of which we are1596 metric tons of biodiesel revenue was in processtransit as of fulfillingSeptember 30, 2023 and would be recognized as revenue during the order.fourth quarter. 

 

35

(Tabular data in thousands, except par value and per share data)

 

Results of Operations

 

Three Months Ended March 31,September 30, 2023, Compared to Three Months Ended March 31,September 30, 2022

 

Revenues

 

Our revenues are derived primarily from sales of ethanol and WDG for our California Ethanol segment, renewable natural gas for our Dairy Renewable Natural Gas segment, biodiesel and refined glycerinbiodiesel for our India Biodiesel and sublease rental income from All Other.segment.

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $47,439  $60,908  $(13,469)  (22.1)%

California Dairy Renewable Natural Gas

  1,107   308   799   259.4%

India Biodiesel

  20,144   10,923   9,221   84.4%

Eliminations

  -   (308)  308   (100.0)%

Total

 $68,690  $71,831  $(3,141)  (4.4)%

 

California Ethanol. For the three months ended March 31,September 30, 2023, the Company generated revenue from thesold 13.8 million gallons of ethanol remaining in inventory at December 31, 2022, consistingan average price of 147$2.64 per gallon and 98 thousand gallonstons of WDG at a price of $2.50$96 per gallon. Sales of WDG, corn oil, CDS and CO₂ were not material. Revenues from California Ethanol segment forton. For the three months ended March 31, 2023, were $475September 30, 2022, the Company sold 15.7 gallons of ethanol at an average price of $2.85 per gallon and 102 thousand compared to $52.0 million for the three months ended March 31, 2022.tons of WDG at a price of $127 per ton. The decrease in revenuesrevenue was dueattributable to an extended maintenance cycle and accelerated the implementation of several important ethanol energy efficiency plant upgrades to the Keyes Plant during the first quarter of 2023. decrease in sales volume by 12% coupled with decrease in average price by 7%.

 

California Dairy Renewable Natural Gas. During the three months ended March 31,September 30, 2023, we produced and sold 21.3 thousandsold 66.6 thousand MMBtu of physical moleculesrenewable natural gas to an external party, at an average price of $9.67$2.13 per MMBtu while placing the carbon credits in storage for sale once the LCFS pathway for the carbon credits are verified.and we also sold 271 thousand D3 RINs at average price of $2.97 per RIN. During the three months ended March 31,September 30, 2022, we produced and sold to an intercompany party 14.016.8 thousand MMBtus of dairy biogas.biogas that we used at the Keyes plant.

 

India BiodieselFor the three months ended March 31,September 30, 2023, we generated 81%96% of our revenues from the sale of biodiesel, and 19%4% of our sales from other sales compared to 100%99% of our sales from biodiesel, and 1% of our sale from other sales for the three months ended March 31,September 30, 2022. Revenues from India Biodiesel segment for the three months ended March 31, 2023, were $1.5 million, compared to $8 thousand for the three months ended March 31, 2022. The increase in revenues was primarily attributable to obtaining the tender offers from India's Oil Market Companies, making the production of biodiesel sales to mining customers ascommercially viable for the biodiesel price is commercially viable.Company. Biodiesel sales volume increased by 100% to 1.015.5 thousand metric tons in the three months ended March 31,September 30, 2023 compared to 07.0 thousand metric tons in the three months ended March 31,September 30, 2022 while price per ton decreased by 27%.

 

36

(Tabular data in thousands, except par value and per share data)

 

Cost of Goods Sold

 

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $48,912  $64,671  $(15,759)  (24.4)%

California Dairy Renewable Natural Gas

  1,914   487   1,427   293.0%

India Biodiesel

  17,372   8,082   9,290   114.9%

All other

  -   3   (3)  (100.0)%

Eliminations

  -   (308)  308   (100.0)%

Total

 $68,198  $72,935  $(4,737)  (6.5)%

California Ethanol. Due to an extended maintenance cycle and an accelerated implementation of several important ethanol energy efficiency plant upgrades at the Keyes Plant during the first quarter of 2023, we did not grind any corn inFor the three months ended March 31, 2023.  FixedSeptember 30, 2023, we ground 5.0 million bushels of corn at $7.48 per bushel and incurred $1.9 million in chemicals and denaturant costs, for$2.2 million in natural gas costs, of goods soldand $2.2 million in thetransportation costs. F amount of $2.7 million were reclassified to selling, general and administrative expense. As a result, foror the three months ended March 31, 2023September 30, 2022, wewe ground 5.5 million bushels of corn at $9.59 per bushel and incurred $43.7$1.7 million less in cornchemicals and denaturant costs, $3.1 $3.8 million less in natural gas costs, $1.7and $2.5 million less in chemical costs, and $1.9 million less in transportation costs compared to the same period in 2022. costs.

 

California Dairy Renewable Natural Gas. Cost of Goods Sold expenses relate to dairy manure payments, maintenance on the dairy digesters, production bonuses, and depreciation. Cost of Goods Sold increased with seven operating dairies as of September 30, 2023, compared to two operating dairies in the three months ended September 30, 2022. 

 

India Biodiesel. The increase in costs of goods sold was attributable to the increase in production of biodiesel to meet mining customer's demand.biodiesel. In the three months ended March 31,September 30, 2023 biodiesel feedstock volume was 1.0we consumed 15.6 thousand metric tons of feedstock, compared to 09.4 thousand metric tons of feedstock in the same period asin 2022. During the three months ended March 31,September 30, 2023 the average price of biodiesel feedstock was $752 per biodiesel metric ton was $876 compared to $0$889 per metric ton in the same period as in 2022.

 

Gross profit (loss)

 

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $(1,473) $(3,763) $2,290   (60.9)%

California Dairy Renewable Natural Gas

  (807)  (179)  (628)  350.8%

India Biodiesel

  2,772   2,841   (69)  (2.4)%

All other

  -   (3)  3   (100.0)%

Total

 $492  $(1,104) $1,596   (144.6)%

California Ethanol. For the three months ended March 31, 2023, gross loss of California Ethanol segment was $12 thousand, compared to $2.9 million for the three months ended March 31, 2022.TheThe decrease in gross loss waswas attributable to an extended maintenance cyclelower corn prices and accelerated implementation of several important ethanol energy efficiency plant upgrades atnatural gas prices in 2023 compared to higher corn prices and natural gas prices in the Keyes Plant during the first quarter of 2023. 2022.

 

California Dairy Renewable Natural Gas. The increase in gross loss in the three months ended March 31,September 30, 2023 relates to an increase in manure and maintenance costs associated with having sixseven dairies online,producing biogas, compared to two dairies in the same period ended March 31,September 30, 2022.

 

India Biodiesel. The increaseslight decrease in gross profit was attributable to decrease in the increase inaverage sales and productionprice of biodiesel to meet mining customer requirements.by 27% and refined glycerin by 33% offset by decrease of feedstock price by 15%. 

 

Operating (income)/expense and non-operating (income)/expense

 

Substantially all of our research and development expenses were related to research and development activities in Minnesota.

 

Selling, general, and administrative (“SG&A”) expenses consist primarily of salaries and related expenses for employees, marketing expenses related to sales of ethanol and WDG in California Ethanol and biodiesel and other products in India Biodiesel, as well as professional fees, insurance, other corporate expenses, and related facilities expenses.

Other operating income consists Also included was of sublease rental income.income which was included as an offset to the SG&A expenses.

 

37

(Tabular data in thousands, except par value and per share data)

 

Other expense (income) expense consists primarily of interest and amortization expense attributable to our debt facilities and those of our subsidiaries and accretion of our Series A preferred units. The debt facilities sometimes include stock or warrants issued as fees. The fair value of stock and warrants are amortized as amortization expense, except when the extinguishment accounting method is applied, in which case refinanced debt costs are recorded as extinguishment expense.

 

Three Months Ended March 31, (in thousands)

 

2023

  

2022

  

Inc/(dec)

  

% change

  

2023

  

2022

  

Inc/(dec)

  

% change

 

Research and development expenses

 $42  $36  $6  16.7% $36  $52  $(16) (30.8)%

Selling, general and administrative expenses

 10,789  7,306  3,483  47.7% 8,985  6,439  2,546  39.5%
         

Other expense (income):

  

Interest expense

  

Interest rate expense

 $7,078  $4,435  $2,643  59.6% $8,749  $5,456  $3,293  60.4%

Debt related fees and amortization expense

 1,969  1,826  143  7.8% 1,433  1,633  (200) (12.2)%

Accretion and other expenses of Series A preferred units

 5,564  1,640  3,924  239.3% 7,739  2,774  4,965  179.0%

Other expense (income)

 (76) (41) (35) 85.4%

Gain on debt extinguishment

 - 49,386 (49,386) (100.0)%

Other (income) expense

 (1,853) (2) (1,851) 92550.0%

 

The increase in SG&A expenses for the three months ended March 31,September 30, 2023 was due to increases in (i) stock compensation, and salaries and wages of $0.4 million, (ii) professional fees of $1.6$1.8 million due to issuing a grantand (iii) miscellaneous expense of RSAs, (ii) Depreciation and Amortization of $1.2$0.6 million due to reclassifying cost of goods sold depreciation, maintenance costs and plant services to SG&A depreciation,during the extended maintenance cycle and (iii) Taxes, Insurances, Rent and Utilities increasethe accelerated implementation of $0.8 million.several important ethanol plant energy efficiency upgrades to the Keyes Plant.

Interest expense increased in the three months ended March 31,September 30, 2023 due to obtaining the Construction Loan having higher debt, balances onadditional borrowings under the Revolving Loans and Revolving Credit Facilities, and having higherthe impact of rising interest rates on our variable interest ratesrate debt compared to the same period in the prior year. The increase in accretion and other expenses of the Series A Preferred Units was due to accelerated accretionprovisions of the PUPA Amendments. 

Nine Months Ended September 30, 2023, Compared to Nine Months Ended September 30, 2022

Revenues

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $59,246  $178,840  $(119,594)  (66.9)%

California Dairy Renewable Natural Gas

  1,523   940   583   62.0%

India Biodiesel

  55,184   10,941   44,243   404.4%

All other

  -   -   -   0.0%

Eliminations

  -   (940)  940   (100.0)%

Total

 $115,953  $189,781  $(73,828)  (38.9)%

California Ethanol. For the nine months ended September 30, 2023, the Company sold 16.7 million gallons of ethanol at a price of $2.72 per gallon and 122 thousand tons of WDG at a price of $98 per ton. The decrease in revenues was due to an extended maintenance cycle and accelerated the PUPA Amendment. implementation of several important ethanol plant energy efficiency upgrades to the Keyes Plant during the first five months of 2023 coupled with decrease in average price of ethanol by 5% and WDG by 24%.

 

California Dairy Renewable Natural Gas. During the nine months ended September 30, 2023, we produced and sold 142 thousand MMBtu of physical molecules to an external party, at an average price of $5.06 per MMBtu. Also, we started selling D3 RINs during the quarter and we sold 271 thousand D3 RINS at an average price of $2.97 per RIN.  During the nine months ended September 30, 2022, we produced and sold dairy biogas of $940 thousand to an intercompany party.

India Biodiesel.  For the nine months ended September 30, 2023, we generated 97% of our revenues from the sale of biodiesel, and 3% of our sales from other sales compared to 100% of our sales from other sales for the nine months ended September 30, 2022.  The increase in revenues was primarily attributable to receiving the tender offer from the India Oil Marketing Companies, which made the production of biodiesel commercially viable for the Company. Biodiesel sales volume increased to 43.7 thousand metric tons in the nine months ended September 30, 2023 compared to 7.0 thousand metric tons in the nine months ended September 30, 2022, while price per ton decreased to $1,219 per metric ton from $1,550 per metric ton.

38

(Tabular data in thousands, except par value and per share data)

Cost of Goods Sold

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $63,053  $185,635  $(122,582)  (66.0)%

California Dairy Renewable Natural Gas

  4,167   1,394   2,773   198.9%

India Biodiesel

  47,580   8,082   39,498   100.0%

All other

  -   13   (13)  (100.0)%

Eliminations

  -   (940)  940   (100.0)%

Total

 $114,800  $194,184  $(79,384)  (40.9)%

California Ethanol. For the nine months ended September 30, 2023, we ground 6.4 million bushels of corn at $7.34 per bushel. This decrease from the same period in 2022 was due to an extended maintenance period at the Keyes Plant. As a result of the Keyes Plant shutdown, our corn costs decreased by $105.0 million, natural gas costs decreased by $8.0 million, chemical and denaturant costs decreased by $2.5 million, and transportation costs decreased by $3.9 million compared to the same period in 2022. 

California Dairy Renewable Natural Gas. Cost of Goods Sold expenses relate to dairy manure payments, maintenance on the dairy digesters, and depreciation. Cost of goods sold will continue to increase as we expand the business.

India Biodiesel. The increase in costs of goods sold was attributable to increased production. In the nine months ended September 30, 2023 biodiesel feedstock volume was 43.7 thousand metric tons, compared to 9.4 thousand metric tons in the same period as in 2022. During the nine months ended September 30, 2023 the average price of biodiesel feedstock was $797 per metric ton compared to $889 per metric ton in the same period as in 2022.

Gross profit (loss)

  

2023

  

2022

  

Inc/(dec)

  

% change

 

California Ethanol

 $(3,807) $(6,795) $2,988   (44.0)%

California Dairy Renewable Natural Gas

  (2,644)  (454)  (2,190)  482.4%

India Biodiesel

  7,604   2,859   4,745   166.0%

All other

  -   (13)  13   (100.0)%

Total

 $1,153  $(4,403) $5,556   (126.2)%

California Ethanol. The decrease in gross loss was attributable to an extended maintenance cycle for first five months of 2023 coupled with decrease in corn price by 23% and natural gas prices by 52%. 

California Dairy Renewable Natural Gas. The increase in gross loss in the nine months ended September 30, 2023 relates to an increase in manure and maintenance costs associated with having seven dairies producing biogas, compared to two dairies in the same period ended September 30, 2022.

India Biodiesel. The increase in gross profit was attributable to the increase in production and sales of biodiesel to meet the government of India's tender offer as the tender offer was received at the start of the first quarter.

39

(Tabular data in thousands, except par value and per share data)

Operating (income)/expense and non-operating (income)/expense

  

2023

  

2022

  

Inc/(dec)

  

% change

 

Research and development expenses

 $115  $139  $(24)  (17.3)%

Selling, general and administrative expenses

  29,480   21,166   8,314   39.3%

Other expense (income):

                

Interest expense

                

Interest rate expense

 $24,126  $14,819  $9,307   62.8%

Debt related fees and amortization expense

  4,732   5,199   (467)  (9.0)%

Accretion and other expenses of Series A preferred units

  20,188   5,920   14,268   241.0%

Loss on debt extinguishment

  -   49,386   (49,386)  (100.0)%

Gain on litigation

  -   (1,400)  1,400   (100.0)%

Other expense (income)

  (2,020)  (14,297)  12,277   (85.9)%

The increase in SG&A expenses for the nine months ended September 30, 2023 was due to increases in (i) stock compensation, salaries and wages of $2.8 million due to issuing a grant of RSAs, (ii) Depreciation and Amortization of $1.7 million due to reclassifying cost of goods sold depreciation to SG&A depreciation, (iii) Taxes, Insurances, Rent and Utilities increase of $1.1 million, (iv) supplies, other services and professional fees of $2.3 million  and (v) Miscellaneous expense increase of $1.8 million as we reclassified cost of goods sold to SG&A as we were not operating the Keyes Plant until the end of May.

Interest expense increased in the nine months ended September 30, 2023 additional Construction Loan debt, additional borrowings under the Revolving Loans and Revolving Credit Facilities, and the impact of rising interest rates on our variable interest rate debt compared to the same period in the prior year. The increase in accretion and other expenses of the Series A Preferred Units was due to provisions of the recent PUPA Amendments.

Liquidity and Capital Resources

 

Cash and Cash Equivalents

 

Cash and cash equivalents were $4.1$3.9 million at March 31,September 30, 2023, of which $1.4$0.8 million was held in NorthNorth America and the rest was held at our Indian subsidiary. Our current ratio at March 31,September 30, 2023 decreased to 0.20 compared to our current ratio of was 0.21 awhich stayed same as at t December 31, 2022.2022. We expect that our future available liquidity resources will consist primarily of cash generated from operations, remaining cash balances, borrowings available, if any, under our senior debt facilities and our subordinated debt facilities, and any additional funds raised through sales of equity. The use of proceeds from all equity raises and debt financings are subject to approval by our senior lender.

 

Liquidity

 

Cash and cash equivalents, current assets, current liabilities and debt at the end of each period were as follows (in thousands):follows:

 

 

As of

  

As of

 
 

March 31, 2023

  

December 31, 2022

  

September 30, 2023

  

December 31, 2022

 

Cash and cash equivalents

 $4,131  $4,313  $3,899  $4,313 

Current assets (including cash, cash equivalents, and deposits)

 21,224  18,136  78,491  18,136 

Current and long-term liabilities (excluding all debt)

 170,866  162,728  190,897  162,728 

Current & long-term debt

 261,935  246,240  286,534  246,240 

 

Our principal sources of liquidity have been cash provided by the sale of equity, operations, and borrowings under various debt arrangements.

 

We launched an EB-5 Phase II funding in 2016, under which we expect to issue $50.8 million in additional EB-5 Notes on substantially similar terms and conditions as those issued under our EB-5 Phase I funding. On November 21, 2019, the minimum investment amount was raised from $0.5 million per investor to $0.9 million per investor. As of March 31, 2023, EB-5 Phase II funding in the amount of $4.0 million had been released from escrow to us. Our principal uses of cash have been to refinance indebtedness, fund operations, and for capital expenditures. We anticipate these uses will continue to be our principal uses of cash in the future. Global financial and credit markets have been volatile in recent years, and future adverse conditions of these markets could negatively affect our ability to secure funds or raise capital at a reasonable cost, or at all.

 

We operate in a volatile market in which we have limited control over the major components of input costs and product revenues and are making investments in future facilities and facility upgrades that improve the overall margin while lessening the impact of these volatile markets.  As such, we expect cash provided by operating activities to fluctuate in future periods primarily because of changes in the prices for corn, ethanol, WDG, DCO, CDS, biodiesel, waste fats and oils, glycerin, non-refined palm oil, natural gas federal RINs and natural gas.LCFS credits. To the extent that we experience periods in which the spread between ethanol prices, and corn and energy costs narrow or the spread between biodiesel prices and waste fats and oils or palm oil and energy costs narrow, we may require additional working capital to fund operations.

 

As a result of negative capital, negative market conditions, negative operating results, and collateralization of substantially all of the company assets, the Company has been reliant on its senior secured lender to provide additional funding and has been required to remit substantially all excess cash from operations to the senior secured lender. In order to meet its obligations during the next twelve months, the Company will need to either refinance the Company’s debt or receive the continued cooperation of its senior lender. This dependence on the senior lender raises substantial doubt about the Company’s ability to continue as a going concern. The Company plans to pursue the following strategies to improve the course of the business.

 

For the Keyes Plant, we plan to restartrestarted the plant during the second quarter now that theafter completing an extended maintenance cycle is complete,and accelerating the implementation of several important ethanol plant energy efficiency upgrades. We plan to operate the plant and continue to improve its financial performance by completing the existing upgrades and adopting new technologies orand process changes that allow for energy efficiency, cost reduction or revenue enhancements, as well as, executeexecuting upon awarded grants that improve energy and operational efficiencies resulting in lower cost, lower carbon demands and overall margin improvement.

 

3840

(Tabular data in thousands, except par value and per share data)

 

For Aemetis Biogas, we plan to operate the biogas digesters to capture and monetize biogas as well as continue to build new dairy digesters and extend the existing pipeline in order to capture the higher carbon credits available in California. Funding for continued construction is based upon obtaining government guaranteed loans and executing on existing and new state grant programs.

For the Riverbank project, we plan to raise the funds necessary to construct and operate the Carbon Zero plant in Riverbank, CA using loan guarantees and public financings based upon the licensed technology that generate federal and state carbon credits available for ultra-low carbon fuels utilizing lower cost, non-food advanced feedstocks to significantly increase margins.

For all facilities in the United States, we plan to utilize the provision of the Inflation Reduction Act of 2022 by qualifying for renewable energy credits, whether in the form of an Investment Tax Credit, Producers Tax Credit or other credits and monetize the credits using the provisions of this congressional act.

 

For the Kakinada Plant, we plan to continue to develop sales channels for domestic products as the costs of feedstock normalize against the price of diesel, as recently announced governmental incentives take effect to promote the blending of biodiesel, and as feedstocks such as refined animal tallow are used domestically and exported. Additionally, we are in the process of obtaining approval to export refined animal tallow and biodiesel produced using animal tallow into international markets as the use of refined animal tallow received approval from the Pollution Control Board of India for production of biodiesel. The repatriation of funds from India to the parent company in the U.S. is reliant on favorable governmental approvals. 

 

For the Riverbank project, we plan to continue project development and raise the funds necessary to construct and operate the Carbon Zero plant in Riverbank, California to produce renewable diesel and sustainable aviation fuel for transportation use as well as generate federal and state carbon credits available for the production and sale of low carbon fuels.

For all facilities in the United States, we plan to utilize the provision of the Inflation Reduction Act of 2022 by qualifying for tax credits in the form of an Investment Tax Credits, Production Tax Credits, and other credits, and to monetize the credits using the provisions of this congressional act.

In addition to the above we plan to continue to locate funding for existing and new business opportunities through a combination of working with our senior lender, restructuring existing loan agreements, selling bonds in the taxable and tax-exempt markets, selling equity through the ATM and otherwise, selling the current EB- 5EB-5 Phase II offering, orand by vendor financing arrangements.

 

At March 31,September 30, 2023,, the outstanding balance of principal, interest and fees, net of discounts, on all Third Eye Capital Notes equaled $164$182 million. The maturity dates for the Third Eye Capital financing arrangements are August 31, 2023, for $11.5 million which was paid off subsequently, April 1, 2024,2025, for $112$125.8 million, March 1, 2025, for $29$25.0 million and March 1, 2026, for $23$24.9 million.

 

As of the date of this report, the Company has $50.0 million additional borrowing capacity to fund future cash flow requirements under the Reserve Liquidity Notes with a maturity date April 1, 2024.

 

We also rely on our working capital lines with Gemini, Secunderabad Oils, and Leo Edibles & Fats India Ltd. in India to fund our commercial arrangements for the acquisitions of feedstock. We currently provide our own working capital for the Keyes Plant; Gemini and Secunderabad Oils currently provide us with working capital for the Kakinada Plant. The ability of Gemini, Secunderabad Oils, and Leo Edibles to continue to provide us with working capital depends in part on both of their respective financial strength and banking relationships.

3941

(Tabular data in thousands, except par value and per share data)

 

Change in Working Capital and Cash Flows

 

The belowfollowing table (in thousands) describes the changes in current and long-term debt during the threenine months ended March 31,September 30, 2023:

 

Increases to debt:

  

Accrued interest

 $7,439     $24,619    

Maturity date extension fee and other fees added to senior debt

 1,732     2,330    

Sub debt extension fees

 340     680    

Revolving Notes Series B draw

 800    

Fuels Revolving Line draw

 1,138     6,598    

Construction Loan draw

 1,570     13,598    

Working capital loan draw

 8,840     22,427    

Total increases to debt

    $21,059     $71,052 

Decreases to debt:

  

Principal, fees, and interest payments to senior lender

 $(1,137)    $(5,445)   

Principal and interest payments to EB-5 investors

 (53)    (148)   

Change in debt issuance costs, net of amortization

 (1,065)    (1,254)   

Term loan payments

 (2)     (7)    

Construction Loan Payments

 (363)    (1,228)   

Working capital loan payments

 (2,744)     (22,676)    

Total decreases to debt

    $(5,364)    $(30,758)

Change in total debt

    $15,695     $40,294 

 

Working capital changeschanges resulted in (i) a $7.9$3.5 million increase in inventories due to UBPL procuringthe Keyes Plant restarting operations and built up of inventory for production for winter months in anticipation of obtaining a new government tender in the second quarter of 2023, partially offset byIndia (ii) a $1.0$3.3 million decreaseincrease in accounts receivable due to lower California Ethanol revenue,UBPL fulfilling a government tender in the third quarter of 2023, and (iii) a $2.7slight increase in other current assets of $0.2 million due to receipt of the restricted cash from the Construction loan. This was partially offset by (i) a $1.4 million decrease in prepaid expenses mainly due to the use of a J.D. Heiskell pre-payment, (iv)and (iii) a decrease in other current assets of $0.9 million, and (v) a $0.2$0.4 million decrease in cash.

 

Net cash used in operating activities during the threenine months ended March 31,September 30, 2023, was $11.3$19.2 million, consisting of non-cash charges of $11.7$36.7 million, net cash providedused by operating assets and liabilities of $3.4$34.8 million, and net loss of $26.4$21.0 million. The non-cash charges consisted of: (i) $2.0$4.8 million in amortization of debt issuance costs and other intangible assets, (ii) $1.8$5.2 million in depreciation expenses, (iii) $2.7$6.2 million in stock-based compensation expense and a warrant grant to our working capital partner, (iv) $5.6$20.2 million in preferred unit accretion and other expenses of Series A preferred units, and (v) $0.3 million change in deferred tax benefit.units. Net changes in operating assets and liabilities consisted primarily of (i) an increase in accrued interest of $5.4$18.5 million, (ii) prepaid expenses decrease of $2.3 million, (iii) an increase in accounts payable of $3.0$4.7 million, (iii) an increase in other liabilities of $3.3 million, and (iv) a decrease in accounts receivableprepaid expenses of $1.0 million, and (v) a decrease in other assets of $0.5$2.4 million. This was partially offset by an increase in (i)other assets of $56.8 million, (ii) an increase in inventories of $7.9$3.6 million and (ii) a decrease(iii) an increase in other liabilitiesaccounts receivable of $0.8$3.3 million.

 

Cash used by investing activities was $0.9$10.9 million, of which $7.6$18.6 million were used by capital projects, partially offset by grant proceeds and other reimbursements of $6.8$7.7 million.

 

Cash provided by financing activities was $11.4$30.6 million, consisting of $2.6$14.8 million from issuance of common stock and $11.6$41.4 million from proceeds from borrowings, partially offset by repayments of borrowings of $2.7$22.6 million, payment of debt renewal and waiver fees of $1.7 million and payments on finance leases of $0.1$1.4 million.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of net sales and expenses for each period. We believe that of our most significant accounting policies and estimates, defined as those policies and estimates that we believe are the most important to the portrayal of our financial condition and results of operations and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain are: revenue recognition; recoverability of long-lived assets, Series A Preferred unit liability, and debt modification and extinguishment accounting. These significant accounting principles are more fully described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

4042

(Tabular data in thousands, except par value and per share data)

 

Recently Issued Accounting Pronouncements

 

None reported beyond those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

Off Balance Sheet Arrangements

 

We had no off-balance sheet arrangements during the three months ended March 31,September 30, 2023.

 

Item 3.          Quantitative and Qualitative Disclosures about Market Risk.

 

Not Applicable.

 

Item 4.          Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures.

 

Management (with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act). Based on this evaluation, our CEO and CFO concluded that, although remediation plans were initiated to address the material weaknesses over financial reporting as identified in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, the disclosure controls and procedures along with the related internal controls over financial reporting were not effective to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and is compiled and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal controls over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

As discussed in greater detail under Item 9A, Controls and Procedures, in our Annual Report on Form 10-K for the year ended December 31, 2022, we initiated a remediation plan to address the material weakness in our internal control related to information technology general controls and information technology systems.

 

For a more comprehensive discussion of the material weaknesses in internal control over financial reporting identified by management as of December 31, 2022, and the remedial measures undertaken to address these material weaknesses, investors are encouraged to review Item 9A, Controls and Procedures, in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

4143

(Tabular data in thousands, except par value and per share data)
 

PART II -- OTHER INFORMATION

 

Item 1. Legal ProceedingsProceedings.

 

The Company has been namedis subject to legal proceedings and claims which arise in various lawsuits or threatened actions that are incidental to ourthe ordinary course of its business. For additional information regarding such matters, see “Part I, Item 1. Financial Statements – Note 5. Commitments and Contingencies - Legal Proceedings.”

 

Item 1A. Risk Factors.

 

NoThere has been no change in risk factors since the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March 9, 2023. We urge you to read the risk factors contained therein.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the firstthird quarter of 2023, we issued two-year warrants to purchase 113 thousand shares of our common stock to certain subordinated promissory note holders pursuant tolenders in connection with a extension of their debt, and we also issued 113 thousand shares of common stock in connection with their exercise of the note holders’ warrant exercise at an exercise price of $0.01 per share.

The above issuance waswarrants.  These issuances were exempt from registration under Section 4(2) of the Securities Act of 1933, as amended, as salesissuances of securities not involving any public offering.

 

Item 3. Defaults Upon Senior Securities.

 

No unresolved defaults on senior securities occurred during the threenine months ended March 31,September 30, 2023.

 

Item 4. Mine Safety Disclosures.

 

None.

 

Item 5. Other Information.

 

None.

 

4244

 

Item 6. Exhibits.

 

31.1

10.1

Fourth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, dated as of November 8, 2023, by and among Aemetis Biogas LLC, Protair-X Americas, Inc. and Third Eye Capital Corporation.

31.1Certifications pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  

31.2

Certifications pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.

  

32.1

Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

  

32.2

Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

10.1Limited Waiver and Amendment No. 26 to Amended and Restated Note Purchase Agreement, dated as of May 5, 2023 by and among Aemetis, Inc.; Aemetis Advanced Fuels Keyes, Inc.; Aemetis Facility Keyes, Inc.; and Third Eye Capital Corporation, an Ontario corporation, as agent for Ninepoint - TEC Private Credit Fund and Third Eye Capital Credit Opportunities Fund - Insight Fund.
  

101.INS *

Inline XBRL Instance Document

  

101.SCH *

Inline XBRL Taxonomy Extension Schema

  

101.CAL *

Inline XBRL Taxonomy Extension Calculation Linkbase

  

101.DEF *

Inline XBRL Taxonomy Extension Definition Linkbase

  

101.LAB *

Inline XBRL Taxonomy Extension Label Linkbase

  

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase

  

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

4345

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

AEMETIS, INC.

  

 

   
Date: November 9, 2023

By:

/s/ Eric A. McAfee

  

Eric A. McAfee

Chief Executive Officer

(Principal Executive Officer)

   

Date: May 5, 2023

 

 

 

Date: November 9, 2023

By:

/s/ Todd Waltz

  

Todd Waltz

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

   

Date: May 5, 2023

 

4446